<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care - Smedemark, SA - 2022 | Cochrane Library</title> <meta content="Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care - Smedemark, SA - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010130.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care - Smedemark, SA - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010130.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010130.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care" name="citation_title"/> <meta content="Siri Aas Smedemark" name="citation_author"/> <meta content="siri.aas.smedemark@rsyd.dk" name="citation_author_email"/> <meta content="Rune Aabenhus" name="citation_author"/> <meta content="University of Copenhagen" name="citation_author_institution"/> <meta content="Carl Llor" name="citation_author"/> <meta content="Anders Fournaise" name="citation_author"/> <meta content="Ole Olsen" name="citation_author"/> <meta content="Department of Public Health, University of Copenhagen" name="citation_author_institution"/> <meta content="Karsten Juhl Jørgensen" name="citation_author"/> <meta content="Rigshospitalet Dept 7112" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010130.pub3" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/10/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010130.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010130.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010130.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Anti-Bacterial Agents [therapeutic use]; Biomarkers; C-Reactive Protein [analysis]; Inflammation; Point-of-Care Testing; Prescriptions; Primary Health Care; Procalcitonin [therapeutic use]; Randomized Controlled Trials as Topic; *Respiratory Tract Infections [diagnosis, drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010130.pub3&amp;doi=10.1002/14651858.CD010130.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010130\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010130\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","ms","fr","hu","zh_HANS","zh_HANT","th","ja","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010130.pub3",title:"Biomarkers as point\\u2010of\\u2010care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care",firstPublishedDate:"Oct 17, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010130.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010130.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010130.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010130.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010130.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010130.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010130.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010130.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010130.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010130.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7040 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010130.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0137"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0057"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-sec-0119"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/appendices#CD010130-sec-0142"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/supinfo/CD010130StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/supinfo/CD010130StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#CD010130-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Siri Aas Smedemark</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#CD010130-cr-0005">Rune Aabenhus</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#CD010130-cr-0006">Carl Llor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#CD010130-cr-0007">Anders Fournaise</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#CD010130-cr-0008">Ole Olsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information#CD010130-cr-0009">Karsten Juhl Jørgensen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information/en#CD010130-sec-0155">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 October 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010130.pub3">https://doi.org/10.1002/14651858.CD010130.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010130-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010130-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010130-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010130-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010130-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010130-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD010130-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010130-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010130-abs-0001" lang="en"> <section id="CD010130-sec-0001"> <h3 class="title" id="CD010130-sec-0001">Background</h3> <p>Acute respiratory infections (ARIs) are by far the most common reason for prescribing an antibiotic in primary care, even though the majority of ARIs are of viral or non‐severe bacterial aetiology. It follows that in many cases antibiotic use will not be beneficial to a patient's recovery but may expose them to potential side effects. Furthermore, limiting unnecessary antibiotic use is a key factor in controlling antibiotic resistance. One strategy to reduce antibiotic use in primary care is point‐of‐care biomarkers. A point‐of‐care biomarker (test) of inflammation identifies part of the acute phase response to tissue injury regardless of the aetiology (infection, trauma, or inflammation) and may be used as a surrogate marker of infection, potentially assisting the physician in the clinical decision whether to use an antibiotic to treat ARIs. Biomarkers may guide antibiotic prescription by ruling out a serious bacterial infection and help identify patients in whom no benefit from antibiotic treatment can be anticipated. This is an update of a Cochrane Review first published in 2014. </p> </section> <section id="CD010130-sec-0002"> <h3 class="title" id="CD010130-sec-0002">Objectives</h3> <p>To assess the benefits and harms of point‐of‐care biomarker tests of inflammation to guide antibiotic treatment in people presenting with symptoms of acute respiratory infections in primary care settings regardless of patient age. </p> </section> <section id="CD010130-sec-0003"> <h3 class="title" id="CD010130-sec-0003">Search methods</h3> <p>We searched CENTRAL (2022, Issue 6), MEDLINE (1946 to 14 June 2022), Embase (1974 to 14 June 2022), CINAHL (1981 to 14 June 2022), Web of Science (1955 to 14 June 2022), and LILACS (1982 to 14 June 2022). We also searched three trial registries (10 December 2021) for completed and ongoing trials. </p> </section> <section id="CD010130-sec-0004"> <h3 class="title" id="CD010130-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) in primary care patients with ARIs that compared the use of point‐of‐care biomarkers with standard care. We included trials that randomised individual participants, as well as trials that randomised clusters of patients (cluster‐RCTs). </p> </section> <section id="CD010130-sec-0005"> <h3 class="title" id="CD010130-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data on the following primary outcomes: number of participants given an antibiotic prescription at index consultation and within 28 days follow‐up; participant recovery within seven days follow‐up; and total mortality within 28 days follow‐up. We assessed risk of bias using the Cochrane risk of bias tool and the certainty of the evidence using GRADE. We used random‐effects meta‐analyses when feasible. We further analysed results with considerable heterogeneity in prespecified subgroups of individual and cluster‐RCTs. </p> </section> <section id="CD010130-sec-0006"> <h3 class="title" id="CD010130-sec-0006">Main results</h3> <p>We included seven new trials in this update, for a total of 13 included trials. Twelve trials (10,218 participants in total, 2335 of which were children) evaluated a C‐reactive protein point‐of‐care test, and one trial (317 adult participants) evaluated a procalcitonin point‐of‐care test. The studies were conducted in Europe, Russia, and Asia. Overall, the included trials had a low or unclear risk of bias. However all studies were open‐labelled, thereby introducing high risk of bias due to lack of blinding. </p> <p>The use of C‐reactive protein point‐of‐care tests to guide antibiotic prescription likely reduces the number of participants given an antibiotic prescription, from 516 prescriptions of antibiotics per 1000 participants in the control group to 397 prescriptions of antibiotics per 1000 participants in the intervention group (risk ratio (RR) 0.77, 95% confidence interval (CI) 0.69 to 0.86; 12 trials, 10,218 participants; I² = 79%; moderate‐certainty evidence).  </p> <p>Overall, use of C‐reactive protein tests also reduce the number of participants given an antibiotic prescription within 28 days follow‐up (664 prescriptions of antibiotics per 1000 participants in the control group versus 538 prescriptions of antibiotics per 1000 participants in the intervention group) (RR 0.81, 95% CI 0.76 to 0.86; 7 trials, 5091 participants; I² = 29; high‐certainty evidence). </p> <p>The prescription of antibiotics as guided by C‐reactive protein tests likely does not reduce the number of participants recovered, within seven or 28 days follow‐up (567 participants recovered within seven days follow‐up per 1000 participants in the control group versus 584 participants recovered within seven days follow‐up per 1000 participants in the intervention group) (recovery within seven days follow‐up: RR 1.03, 95% CI 0.96 to 1.12; I² = 0%; moderate‐certainty evidence) (recovery within 28 days follow‐up: RR 1.02, 95% CI 0.79 to 1.32; I² = 0%; moderate‐certainty evidence). The use of C‐reactive protein tests may not increase total mortality within 28 days follow‐up, from 1 death per 1000 participants in the control group to 0 deaths per 1000 participants in the intervention group (RR 0.53, 95% CI 0.10 to 2.92; I² = 0%; low‐certainty evidence). </p> <p>We are uncertain as to whether procalcitonin affects any of the primary or secondary outcomes because there were few participants, thereby limiting the certainty of evidence. </p> <p>We assessed the certainty of the evidence as moderate to high according to GRADE for the primary outcomes for C‐reactive protein test, except for mortality, as there were very few deaths, thereby limiting the certainty of the evidence. </p> </section> <section id="CD010130-sec-0007"> <h3 class="title" id="CD010130-sec-0007">Authors' conclusions</h3> <p>The use of C‐reactive protein point‐of‐care tests as an adjunct to standard care likely reduces the number of participants given an antibiotic prescription in primary care patients who present with symptoms of acute respiratory infection. The use of C‐reactive protein point‐of‐care tests likely does not affect recovery rates. It is unlikely that further research will substantially change our conclusion regarding the reduction in number of participants given an antibiotic prescription, although the size of the estimated effect may change.  </p> <p>The use of C‐reactive protein point‐of‐care tests may not increase mortality within 28 days follow‐up, but there were very few events. Studies that recorded deaths and hospital admissions were performed in children from low‐ and middle‐income countries and older adults with comorbidities.  </p> <p>Future studies should focus on children, immunocompromised individuals, and people aged 80 years and above with comorbidities. More studies evaluating procalcitonin and potential new biomarkers as point‐of‐care tests used in primary care to guide antibiotic prescription are needed.  </p> <p>Furthermore, studies are needed to validate C‐reactive protein decision algorithms, with a specific focus on potential age group differences.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010130-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010130-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010130-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010130-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010130-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010130-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hu#CD010130-abs-0010">Magyar</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010130-abs-0018">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010130-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010130-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010130-abs-0021">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010130-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD010130-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010130-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010130-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010130-abs-0002" lang="en"> <h3>Can tests for inflammation help doctors decide whether to use antibiotics for airway infections? </h3> <p><b>Key messages </b> </p> <p>1. When a patient presents with symptoms of an airway infection at the doctor's office, the doctor's use of <i>C‐reactive protein point‐of‐care tests</i> during the visit probably reduces the number of patients given an antibiotic prescription, without affecting patient recovery. </p> <p>2. We do not know if <i>procalcitonin point‐of‐care tests</i> have an effect on antibiotic use or patient recovery. </p> <p>3. Future studies should focus on children, people with diseases of the immune system, and people aged 80 years and above with comorbidities (additional medical conditions). Studies evaluating procalcitonin and new biomarkers to guide antibiotic prescription are recommended.  </p> <p><b>What are point‐of‐care tests?</b> </p> <p>Point‐of‐care tests need only a few drops of blood and are taken during a consultation, providing results within 3 to 20 minutes. This means that blood samples do <i>not</i> need to be transported to a laboratory, and results can be used immediately to make treatment choices during a visit to the doctor. There are point‐of‐care tests that can detect different substances in the blood that your body produces in response to inflammation. These substances are called biomarkers.  </p> <p><b>What is inflammation and biomarkers?</b> </p> <p>Inflammation is a reaction in response to injury such as bacterial or viral infections. Your body naturally produces substances in response to inflammation that can be detected in the blood, which are known as biomarkers. Point‐of‐care tests that detect biomarkers are often used when patients have signs of an airway infection. Test results can inform doctors when <i>not</i> to suspect a serious bacterial infection that needs antibiotic treatment to prevent serious illness and possibly death. There are currently three types of biomarkers available as point‐of‐care tests: C‐reactive protein, procalcitonin, and leucocytes. </p> <p><b>What are antibiotics?</b> </p> <p>Antibiotics are medications used to treat bacterial infections, and they are commonly used for airway infections. However, most airway infections are caused by viruses, such as the common cold, against which antibiotics do not work, and can cause harm. Overuse can lead to antibiotic resistance, which means that antibiotics lose their effectiveness and may no longer be effective against serious infections.   </p> <p><b>Why do we need to investigate whether tests help doctors to decide on antibiotics?</b> </p> <p>No test can provide absolute certainty regarding when to use antibiotics, but correctly used biomarkers could help doctors make the right decision about when to prescribe antibiotics. We investigated if biomarkers as point‐of‐care tests help doctors reduce antibiotic prescriptions.  </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know whether biomarkers as a point‐of‐care test used by primary care doctors can help decide whether to use antibiotics in people with airway infections. </p> <p>We were interested in the effect of biomarker guidance on the number of prescriptions of antibiotics, patient recovery, hospital admissions, and risk of death. </p> <p><b>What did we do?</b> </p> <p>We searched for studies that investigated whether biomarkers used as point‐of‐care tests in primary care can be safely used to guide a doctor's decision whether to prescribe antibiotics. </p> <p>We compared and summarised results of the studies, and rated our confidence of the evidence. </p> <p><b>What did we find?</b> </p> <p>We found 13 studies with a total of 10,535 participants who had symptoms of airway infections and who saw a doctor in a primary care setting for possible treatment.  </p> <p>Twelve studies investigated tests for the biomarker C‐reactive protein, and one study investigated a test for the biomarker procalcitonin.  </p> <p>Use of tests for C‐reactive protein probably reduces the number of patients given an antibiotic prescription, but differences in study design and where the studies took place meant that the precise effect is uncertain. Using these tests probably does not affect the number of patients that recover, and may not reduce the number of patients that feel satisfied with their treatment. C‐reactive protein tests may not lead to an increase in deaths. This means the tests are probably safe when used to guide the prescription of antibiotics. </p> <p>We do not know if procalcitonin tests have an effect on prescriptions of antibiotics, recovery, hospital admissions, or risk of death. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We are moderately confident in the evidence for a reduction in antibiotics use with C‐reactive protein tests. However, we are not confident in the evidence for a reduction in antibiotics use with procalcitonin, as we only found one study investigating the effect of procalcitonin in primary care.  </p> <p>New studies are unlikely to change our conclusion regarding the effect of the use of C‐reactive protein on prescribing antibiotics, but more studies are needed to assess the potential for the procalcitonin point‐of‐care test.  </p> <p><b>How up‐to‐date is this evidence?</b> </p> <p>The evidence is current to June 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010130-sec-0137" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010130-sec-0137"></div> <h3 class="title" id="CD010130-sec-0138">Implications for practice</h3> <section id="CD010130-sec-0138"> <p>Use of C‐reactive protein point‐of‐care tests as an adjunct to taking a medical history and clinical examination of patients with symptoms of acute respiratory infections (ARIs) likely reduces the number of participants given an antibiotic prescription in primary care, and is unlikely to affect recovery within 7 or 28 days follow‐up, or duration of the ARI. C‐reactive protein point‐of‐care tests may not increase mortality or risk of hospital admissions within 28 days follow‐up; however, event numbers for these outcomes were very low, thereby limiting the certainty of evidence.  </p> <p>Clinicians must be aware of the different algorithms/cut‐off points when using C‐reactive protein tests. C‐reactive protein values less than 20 mg/L suggest that antibiotics may be initially withheld, but this cut‐off is not currently validated in children and older adults with comorbidities. </p> <p>At present, C‐reactive protein is the only biomarker available for point‐of‐care test in primary care settings, where evidence supports that it can guide antibiotic prescriptions for ARIs. Furthermore, C‐reactive protein point‐of‐care tests are applicable in primary care, as test results are provided within 2 to 3 minutes. </p> <p>The evidence of is very uncertain about the effect of procalcitonin point‐of‐care test on the number of participants given an antibiotic prescription, recovery, mortality, and hospital admissions. Clinicians must also be aware that procalcitonin point‐of‐care tests currently provide results in 20 minutes. Time to results may therefore limit widespread implementation of this test in primary care.  </p> </section> <h3 class="title" id="CD010130-sec-0139">Implications for research</h3> <section id="CD010130-sec-0139"> <p>C‐reactive protein point‐of‐care tests in children and adults likely reduce the number of participants given an antibiotic prescription for ARIs in primary care. It is unlikely that further research will change our conclusion, although the size of the estimated effect may change.  </p> <p>C‐reactive protein point‐of‐care tests may not increase mortality within 28 days follow‐up, but this assessment was based on very few events and thus low‐certainty evidence. C‐reactive protein point‐of‐care tests are unlikely to affect hospital admissions within 28 days follow‐up. Studies that recorded deaths and hospital admissions were performed in children and older adults with comorbidities in low‐ and middle‐income countries. Future studies should focus on children, immunocompromised individuals, and people aged 80 years and older with comorbidities, and should assess mortality and hospital admission as critically important outcomes.  </p> <p>Furthermore, algorithms/cut‐off points for C‐reactive protein to rule out serious disease are not validated and were used differently in studies included in this review. Future studies are needed to validate C‐reactive protein algorithms/cut‐off points, with specific focus on potential age group differences.   </p> <p>The evidence of is very uncertain about the effect of procalcitonin point‐of‐care test, as only one study investigating procalcitonin point‐of‐care test was identified. More studies are needed to evaluate procalcitonin as well as potential new biomarkers as point‐of‐care tests used in primary care to guide antibiotic prescription.  </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010130-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010130-sec-0008"></div> <div class="table" id="CD010130-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Point‐of‐care biomarkers (C‐reactive protein) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Point‐of‐care biomarker for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> people with acute respiratory infections </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> point‐of‐care biomarker (C‐reactive protein) test </p> <p><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Standard care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>at index consultation</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>516 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>397 per 1000</b> </p> <p>(356 to 444)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> </p> <p>(0.69 to 0.86)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10218 </p> <p>(12 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> <p> </p> <p> </p> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>within 28 days follow‐up</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>664 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>538 per 1000 </b> </p> <p>(505 to 571)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.81</b> </p> <p>(0.76 to 0.86)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5091 </p> <p>(7 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 7 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>567 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>584 per 1000</b> </p> <p>(545 to 636)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b> </p> <p>(0.96 to 1.12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3104</p> <p>(4 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Defined as number of participants at least substantially improved at 7 days follow‐up </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality </b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000 </b> </p> <p>(0 to 2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b> (0.10 to 2.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7737</p> <p>(9 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies reported 5 events. 6 studies had no events. 3 studies did not report on death. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants in need of a hospital admission</b>  </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>14 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> </p> <p>(10 to 22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> </p> <p>(0.72 to 1.53)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7514 </p> <p>(10 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 studies reported 105 events. 4 studies had no events. 2 studies did not report on hospital admission. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>897 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>915 per 1000</b> </p> <p>(724 to 1000)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.02</b> </p> <p>(0.79 to 1.32)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2324 </p> <p>(5 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Defined as number of participants at least substantially improved at 28 days of follow‐up </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The <b>assumed risk</b> was calculated as the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty</b> : we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty</b> : our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty</b>: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded one level due to substantial heterogeneity.<br/><sup>b</sup>We downgraded one level due to risk of bias (lack of blinding).<br/><sup>c</sup>We downgraded two levels due to substantial imprecision.<br/><sup>d</sup>We downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010130-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Point‐of‐care biomarkers (procalcitonin) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Point‐of‐care biomarker for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> people with acute respiratory infections </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> point‐of‐care biomarker (procalcitonin) test </p> <p><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Standard care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>at index consultation</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>566 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>181 per 1000</b> </p> <p>(130 to 249)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.32</b> </p> <p>(0.23 to 0.44)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 </p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>within 28 days follow‐up</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b> </p> <p>(31 to 174)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> </p> <p>(0.44 to 2.48)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 7 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>395 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>486 per 1000</b> </p> <p>(367 to 639)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.23</b> </p> <p>(0.93 to 1.62)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality </b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable due to few participants and events. No events of death occurred in either intervention or control group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants in need of a hospital admission</b>  </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> <p>(9 to 264 more)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.40</b> </p> <p>(0.26 to 7.51)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable, as this outcome was not assessed in the included study</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> was calculated as the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty</b> : we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty</b> : our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty</b>: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded one level for study limitations (cluster‐randomised trial), one level for indirectness (study only included adults), and two levels for substantial imprecision (small sample size compared to the optimal information size). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010130-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010130-sec-0009"></div> <section id="CD010130-sec-0010"> <h3 class="title" id="CD010130-sec-0010">Description of the condition</h3> <p>Since the discovery of the antibacterial effects of penicillins and other antibiotics, they have been one of the most important treatments in modern medicine. Effective antibacterial agents cure bacterial infections, such as pneumonia, and are also essential to ensure that surgery, chemotherapy, and neonatology can be safely delivered. However, antibiotic use can cause antibiotic resistance (<a href="./references#CD010130-bbs2-0072" title="GoossensH , FerechM , Vander SticheleR , ElseviersM . Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet2005;365(9459):579-87.">Goossens 2005</a>), which leads to ineffective treatments, increased risk of serious complications such as bacterial infections and death, and increased healthcare costs (<a href="./references#CD010130-bbs2-0061" title="CarletJ , CollignonP , GoldmannD , GoossensH , GyssensIC , HarbarthS , et al. Society's failure to protect a precious resource: antibiotics. Lancet2011;378(9788):369-71.">Carlet 2011</a>; <a href="./references#CD010130-bbs2-0108" title="SmithR , CoastJ . The true cost of antimicrobial resistance. BMJ2013;346:f1493.">Smith 2013</a>). Combatting antibiotic resistance is therefore a public health priority (<a href="./references#CD010130-bbs2-0121" title="World Health Organization. Global action plan on antimicrobial resistance. www.who.int/publications/i/item/9789241509763  (accessed prior to 8 October 2022).">WHO 2016</a>). Reducing unneeded antibiotic treatments through evidence‐based antibiotic stewardship programmes is essential to preserve the future effectiveness of antibiotics. However, treating acute respiratory infections (ARIs) with antibiotics is common in primary care settings, despite their predominant self‐limiting nature, and frequent viral origins (<a href="./references#CD010130-bbs2-0074" title="HarndenA , PereraR , BrueggemannAB , Mayon-WhiteR , CrookDW , ThomsonA , et al. Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study. Archives of Diseases in Childhood2007;92(7):594-7.">Harnden 2007</a>; <a href="./references#CD010130-bbs2-0099" title="PaviaAT . Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clinical Infectious Diseases2011;52(Suppl 4):284-9.">Pavia 2011</a>; <a href="./references#CD010130-bbs2-0107" title="SmieszekT , PouwelsKB , DolkFC , SmithDR , HopkinsS , SharlandM , et al. Potential for reducing inappropriate antibiotic prescribing in English primary care. Journal of Antimicrobial Chemotherapy2018;73:ii36-43. [DOI: 10.1093/jac/dkx500]">Smieszek 2018</a>), and that antibiotic treatment has been shown to be of marginal benefit in uncomplicated cases (<a href="./references#CD010130-bbs2-0056" title="ButlerCC , HoodK , VerheijT , LittleP , MelbyeH , NuttallJ , et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ2009;338:b2242.">Butler 2009</a>; <a href="./references#CD010130-bbs2-0057" title="ButlerCC , KellyMJ , HoodK , SchabergT , MelbyeH , Serra-PratM , et al. Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection. European Respiratory Journal2011;38(1):119-25.">Butler 2011</a>; <a href="./references#CD010130-bbs2-0088" title="LittleP , StuartB , MooreM , CoenenS , ButlerCC , Godycki-CwirkoM , et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infectious Disease2013;13(2):123-9.">Little 2013b</a>; <a href="./references#CD010130-bbs2-0089" title="LittleP , FrancisNA , StuartB , O'ReillyG , ThompsonN , BecqueT , et al. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet2021;16:1417-26. [DOI: 10.1016/S0140-6736(21)01431-8.]">Little 2021</a>; <a href="./references#CD010130-bbs2-0093" title="MeropolSB , LocalioAR , MetlayJP . Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study. Annals of Family Medicine2013;11(2):165-72.">Meropol 2013</a>; <a href="./references#CD010130-bbs2-0117" title="VenekampRP , SandersS , GlaszioiuPP , Del MarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub4]">Venekamp 2015</a>). Limiting unnecessary antibiotic prescriptions in primary care settings is pivotal to reducing bacterial resistance to antibiotics at both the societal, <a href="./references#CD010130-bbs2-0053" title="BronzwaerSL , CarsO , BuchholzU , MolstadS , GoettschW , VeldhuijzenIK , et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases2002;8(3):278-82.">Bronzwaer 2002</a>; <a href="./references#CD010130-bbs2-0071" title="GonzalesR , MaloneDC , MaselliJH , SandeMA . Excessive antibiotic use for acute respiratory infections in the United States. Clinical Infectious Diseases2001;33(6):757-62.">Gonzales 2001</a>; <a href="./references#CD010130-bbs2-0103" title="Sande-BruinsmaN , GrundmannH , VerlooD , TiemersmaE , MonenJ , GoossensH , et al. Antimicrobial drug use and resistance in Europe. Emerging Infectious Diseases2008;14(11):1722-30.">Sande‐Bruinsma 2008</a>, and individual levels (<a href="./references#CD010130-bbs2-0064" title="CostelloeC , MetcalfeC , LoveringA , MantD , HayAD . Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ2010;340:c2096.">Costelloe 2010</a>), as well as reducing their harmful side effects and drug interactions. A reduction in antibiotic prescriptions in primary care settings will have a large impact on the total use of antibiotics, as the vast majority of antibiotic prescriptions are issued there (<a href="./references#CD010130-bbs2-0046" title="AabenhusR , SiersmaV , HansenMP , BjerrumL . Antibiotic prescribing in Danish general practice 2004-13. Journal of Antimicrobial Chemotherapy2016;71(8):2286-94. [DOI: 10.1093/jac/dkw117]">Aabenhus 2016</a>; <a href="./references#CD010130-bbs2-0100" title="Public Health England. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2020 to 2021. assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1069632/espaur-report-2020-to-2021-16-Nov-FINAL-v2.pdf (accessed prior to 8 October 2022).">Public Health England 2021</a>). Nevertheless, patient safety must be carefully assessed to minimise the risk of undertreatment of serious bacterial infections. </p> <p>Interventions to reduce antibiotic use in primary care other than point‐of‐care tests have been studied (<a href="./references#CD010130-bbs2-0113" title="Tonkin-CrineSK , TanPS , vanHeckeO , WangK , RobertsNW , McCulloughA , et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database of Systematic Reviews2017, Issue 9. Art. No: CD012252. [DOI: 10.1002/14651858.CD012252.pub2]">Tonkin‐Crine 2017</a>), and educational interventions (<a href="./references#CD010130-bbs2-0048" title="ArnoldSR , StrausSE . Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews2009, Issue 1. Art. No: CD003539. [DOI: 10.1002/14651858.CD003539.pub2]">Arnold 2009</a>), including the use of multifaceted approaches and communication skills training, have been shown to be effective (<a href="./references#CD010130-bbs2-0058" title="ButlerCC , SimpsonSA , DunstanF , RollnickS , CohenD , GillespieD , et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ2012;344:d8173.">Butler 2012</a>; <a href="./references#CD010130-bbs2-0070" title="GjelstadS , HoyeS , StraandJ , BrekkeM , DalenI , LindbaekM . Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ2013;347:f4403.">Gjelstad 2013</a>). Letters, with recommendations on how to reduce antibiotic prescription, addressed to primary care physicians with high levels of antibiotic use, have shown an effect on antibiotic prescribing rates (<a href="./references#CD010130-bbs2-0106" title="SchwartzKL , IversN , LangfordBJ , TaljaardM , NeishD , BrownKA , et al. Effect of antibiotic-prescribing feedback to high-volume primary care physicians on number of antibiotic prescriptions: a randomized clinical trial. JAMA Internal Medicine2021;181(9):1165-73. [DOI: 10.1001/jamainternmed.2021.2790.]">Schwartz 2021</a>). Also, a policy of delayed antibiotic prescription can reduce antibiotic use (<a href="./references#CD010130-bbs2-0109" title="SpurlingGK , Del MarCB , DooleyL , FoxleeR , FarleyR . Delayed antibiotic prescriptions for respiratory infections. Cochrane Database of Systematic Reviews2017, Issue 9. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417.pub5]">Spurling 2017</a>). </p> <p>The decision whether to prescribe antibiotics for an ARI in primary care settings is challenging. Patients often expect an antibiotic prescription to enhance recovery (<a href="./references#CD010130-bbs2-0051" title="BoikoO , GullifordMC , BurgessC . Revisiting patient expectations and experiences of antibiotics in an era of antimicrobial resistance: qualitative study. Health Expectations2020;23:1250–8. [DOI: 10.1111/hex.13102]">Boiko 2020</a>). Besides patient's expectations, diagnostic uncertainty is often present with patients presenting with symptoms of an ARI (<a href="./references#CD010130-bbs2-0110" title="StantonN , FrancisNA , ButlerCC . Reducing uncertainty in managing respiratory tract infections in primary care. British Journal of General Practice2010;60(581):e466-75.">Stanton 2010</a>; <a href="./references#CD010130-bbs2-0120" title="WangD ,  LiuC ,  ZhangX ,  LiuC . Does diagnostic uncertainty increase antibiotic prescribing in primary care?NPJ Primary Care Respiratory Medicine2021;31(1):17. [DOI: 10.1038/s41533-021-00229-9.]">Wang 2021</a>). Diagnosing solely based on clinical symptoms is known to have both low sensitivity and specificity (<a href="./references#CD010130-bbs2-0078" title="HoareZ , LimWS . Pneumonia: update on diagnosis and management. BMJ2006;332(7549):1077-9.">Hoare 2006</a>; <a href="./references#CD010130-bbs2-0094" title="MetlayJP , KapoorWN , FineMJ . Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA1997;278(17):1440-5.">Metlay 1997</a>), and high interobserver variability (<a href="./references#CD010130-bbs2-0122" title="WipfJE , LipskyBA , HirschmannJV , BoykoEJ , TakasugiJ , PeugeotRL , et al. Diagnosing pneumonia by physical examination: relevant or relic?Archives of Internal Medicine1999;159(10):1082-7.">Wipf 1999</a>), and may not reliably differentiate between viral and bacterial aetiologies. In accordance with this, there is evidence of substantial between‐practitioner, <a href="./references#CD010130-bbs2-0047" title="AabenhusR , SiersmaV , SandholdtH , Køster-RasmussenR , HansenMP , BjerrumL . Identifying practice-related factors for high-volume prescribers of antibiotics in Danish general practice. Journal of Antimicrobial Chemotherapy2017;72(8):2385-91. [DOI: 10.1093/jac/dkx115.]">Aabenhus 2017</a>; <a href="./references#CD010130-bbs2-0111" title="StocksN , FaherT . Labelling of acute respiratory illness: evidence of between-practitioner variation in the UK. Family Practice2002;19(4):375-7.">Stocks 2002</a>, and geographical variation in antibiotic prescribing patterns, <a href="./references#CD010130-bbs2-0065" title="CurtisHJ , WalkerAJ , MahtaniKR , GoldacreB . Time trends and geographical variation in prescribing of antibiotics in England 1998-2017. Journal of Antimicrobial Chemotherapy2019;74(1):242-50. [DOI: 10.1093/jac/dky377.]">Curtis 2019</a>; <a href="./references#CD010130-bbs2-0091" title="MatthysJ , De MeyereM , vanDrielML , De SutterA . Differences among international pharyngitis guidelines: not just academic. Annals of Family Medicine2007;5(5):436-43.">Matthys 2007</a>, related to socioeconomic and cultural differences between communities. </p> </section> <section id="CD010130-sec-0011"> <h3 class="title" id="CD010130-sec-0011">Description of the intervention</h3> <p>Biomarkers of inflammation, such as white blood cell levels, procalcitonin, and C‐reactive protein, form part of the acute immune response and are activated by endogenous and exogenous stimuli following tissue injury due to infectious conditions such as bacteria and viruses, as well as non‐infectious conditions such as connective tissue diseases and trauma. Circulating levels are low in healthy people, but when stimulated synthesis and recruitment is rapid (less than 20 hours). Levels remain high as long as the inflammation and tissue damage persists, and then decline rapidly (<a href="./references#CD010130-bbs2-0050" title="BeckerKL , NylenES , WhiteJC , MullerB , Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. Journal of Clinical Endocrinology and Metabolism2004;89(4):1512-25.">Becker 2004</a>; <a href="./references#CD010130-bbs2-0119" title="VolanakisJE . Human C-reactive protein: expression, structure, and function. Molecular Immunology2001;38(2-3):189-97.">Volanakis 2001</a>). Biomarkers of inflammation act as surrogate measures of the immune response to infection and may reflect the severity of the condition (i.e. degree of tissue damage and immune activation) (<a href="./references#CD010130-bbs2-0044" title="AabenhusR , JensenJU . Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?Primary Care Respiratory Journal2011;20(4):360-7.">Aabenhus 2011</a>; <a href="./references#CD010130-bbs2-0085" title="KrugerS , EwigS , PapassotiriouJ , KundeJ , MarreR , vonBaumH , et al. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respiratory Research2009;10:65.">Kruger 2009</a>; <a href="./references#CD010130-bbs2-0105" title="SchuetzP , MullerB , Christ-CrainM , StolzD , TammM , BouadmaL , et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD007498. [DOI: 10.1002/14651858.CD007498.pub3]">Schuetz 2017</a>), but cannot determine aetiology (bacterial versus viral) or predict an infiltrate on chest X‐rays (<a href="./references#CD010130-bbs2-0079" title="HolmA , PedersenSS , NexoeJ , ObelN , NielsenLP , KoldkjaerO , et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. British Journal of General Practice2007;57(540):555-60.">Holm 2007</a>; <a href="./references#CD010130-bbs2-0115" title="van derMeerV , NevenAK , vanden BroekPJ , AssendelftWJ . Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ2005;331(7507):26.">van der Meer 2005</a>). No test is able to provide perfect diagnostic accuracy, and false‐negative as well as false‐positive results may occur, leading to possible over‐ or undertreatment of bacterial ARIs. However, in the correct clinical context biomarkers may guide antibiotic prescription in selected cases by ruling out a serious bacterial infection and help identify patients in whom no benefit from antibiotic treatment can be anticipated (<a href="./references#CD010130-bbs2-0092" title="MelbyeH , FrancisNA , ButlerCC . Inflammatory markers are helpful when treating LRTI in primary care. Primary Care Respiratory Journal2011;20(4):367-9.">Melbye 2011</a>; <a href="./references#CD010130-bbs2-0105" title="SchuetzP , MullerB , Christ-CrainM , StolzD , TammM , BouadmaL , et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD007498. [DOI: 10.1002/14651858.CD007498.pub3]">Schuetz 2017</a>). A point‐of‐care test exists for some of these biomarkers to be performed at, or near, the site of patient care, delivering quick test results that can influence clinical decisions (<a href="#CD010130-tbl-0003">Table 1</a>). </p> <div class="table" id="CD010130-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of biomarkers of infection used in acute respiratory infection trials in primary care settings</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Biomarker</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Status</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Handling</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Biochemistry</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>POC test available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Droplet blood from finger prick. Results in approximately 3 minutes. Uninfected adult controls have levels &lt; 10 mg/L. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inflammatory cytokines trigger C‐reactive protein release by the liver. Levels of C‐reactive protein increase within 6 to 18 hours, peaking at 48 to 72 hours. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Leukocyte count</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>POC test available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Droplet blood from finger prick. Results in approximately 3 minutes. Uninfected adult controls have leukocyte levels &lt; 9 x 10⁹/L and neutrocyte levels &lt; 7 x 10⁹/L. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cells of the immune system activated by inflammatory cytokines and foreign antigens.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Procalcitonin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>POC test available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uninfected adult controls have levels &lt; 0.05 ng/mL.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inflammatory cytokines and bacterial endotoxins trigger release of PCT from parenchymal tissues. Levels of PCT increase within 2 to 6 hours, peaking at 24 to 48 hours. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>PCT: procalcitonin<br/>POC: point‐of‐care </p> </div> </div> <p>The decision to prescribe antibiotics for an ARI is guided by prespecified cut‐off values specific to the individual point‐of‐care test, but the test cannot replace clinical skills and expertise, and test results may be overruled on clinical grounds. </p> </section> <section id="CD010130-sec-0012"> <h3 class="title" id="CD010130-sec-0012">How the intervention might work</h3> <p>Following a regular clinical examination that suggests symptoms are indeed compatible with an ARI, a point‐of‐care biomarker may assist the clinician in assessing the likelihood of a serious bacterial infection versus a less severe bacterial or viral infection, thus identifying those patients most likely to benefit from antibiotics (<a href="./references#CD010130-bbs2-0044" title="AabenhusR , JensenJU . Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?Primary Care Respiratory Journal2011;20(4):360-7.">Aabenhus 2011</a>; <a href="./references#CD010130-bbs2-0080" title="HopstakenRM , MurisJW , KnottnerusJA , KesterAD , RinkensPE , DinantGJ . Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. British Journal of General Practice2003;53(490):358-64.">Hopstaken 2003</a>; <a href="./references#CD010130-bbs2-0092" title="MelbyeH , FrancisNA , ButlerCC . Inflammatory markers are helpful when treating LRTI in primary care. Primary Care Respiratory Journal2011;20(4):367-9.">Melbye 2011</a>; <a href="./references#CD010130-bbs2-0105" title="SchuetzP , MullerB , Christ-CrainM , StolzD , TammM , BouadmaL , et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD007498. [DOI: 10.1002/14651858.CD007498.pub3]">Schuetz 2017</a>). If after the clinical examination the clinician is confident in the decision to initiate or withhold antibiotic treatment, there is no need for a point‐of‐care test. Possible detrimental effects of point‐of‐care biomarkers include suboptimal use of time, costs, handling errors, patient dissatisfaction, and false‐negative results that can lead to lack of necessary antibiotic treatments, or false‐positive values that may increase inappropriate antibiotic use. Studies indicate that the use of point‐of‐care tests during consultations is acceptable to both physicians and patients (<a href="./references#CD010130-bbs2-0055" title="ButlerCC , SimpsonS , WoodF . General practitioners' perceptions of introducing near-patient testing for common infections into routine primary care: a qualitative study. Scandinavian Journal of Primary Health Care2008;26:17-21.">Butler 2008</a>; <a href="./references#CD010130-bbs2-0123" title="WoodF , Brookes-HowellL , HoodK , CooperL , VerheijT , GoossensH , et al. An ideal test? A multi-country qualitative study of clinicians' and patients' views of point of care tests for lower respiratory tract infection in primary care. Family Practice2011;28(6):661-9.">Wood 2011</a>). </p> </section> <section id="CD010130-sec-0013"> <h3 class="title" id="CD010130-sec-0013">Why it is important to do this review</h3> <p>Avoiding both over‐ and undertreatment with antibiotics in primary care settings is important to limit antibiotic resistance and exposure of patients to unnecessary risks. So far, the evidence of the effect of using point‐of‐care biomarkers to guide antibiotic prescribing in primary care has mainly been from adults and is of moderate certainty (<a href="./references#CD010130-bbs2-0045" title="AabenhusR , JensenJU , JørgensenKJ , HróbjartssonA , BjerrumL . Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD010130. [DOI: 10.1002/14651858.CD010130]">Aabenhus 2014a</a>; <a href="./references#CD010130-bbs2-0090" title="Martínez-GonzálezN , KeizerA , PlateE , CoenenA , ValeriS , VerbakelF , et al. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials. Antibiotics (Basel, Switzerland) 2020;9(9):610. [DOI: 10.3390/antibiotics9090610]">Martínez‐González 2020</a>). Evidence regarding children and patients who are older or with comorbidities is lacking (<a href="./references#CD010130-bbs2-0060" title="CalsJW , EbellMH . C-reactive protein: guiding antibiotic prescribing decisions at the point of care. British Journal of General Practice2018;68(668):112-3. [DOI: 10.3399/bjgp18X694901]">Cals 2018</a>). </p> <p>We included studies of all available point‐of‐care biomarkers of infection used for ARIs. Updates of this review will therefore include studies of additional point‐of‐care tests as they become available. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010130-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010130-sec-0014"></div> <p>To assess the benefits and harms of point‐of‐care biomarker tests of inflammation to guide antibiotic treatment in people presenting with symptoms of acute respiratory infections in primary care settings regardless of patient age. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010130-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010130-sec-0015"></div> <section id="CD010130-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010130-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised clinical trials (RCTs) and cluster‐RCTs.</p> </section> <section id="CD010130-sec-0018"> <h4 class="title">Types of participants</h4> <p>Primary care patients of all ages with symptoms or a diagnosis of an ARI at study entry. We defined symptoms of ARI as cough, discoloured/increased sputum, fever, runny nose, respiratory distress, feeling unwell, or combinations of focal and systemic symptoms having a duration of less than four weeks. Diagnoses included lower or upper respiratory tract infection, pneumonia, bronchitis, acute exacerbations of chronic obstructive pulmonary disease or asthma, pharyngitis, tonsillitis, laryngitis, rhinosinusitis, common cold, acute otitis media, or influenza. </p> </section> <section id="CD010130-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Point‐of‐care biomarkers of infection to guide antibiotic treatment for ARI in primary care settings. We only included studies of biomarker point‐of‐care tests for infections available for general use. We did not include specific diagnostic tests like the Strep A test or Monospot in this review. We considered the following biomarkers: C‐reactive protein, procalcitonin, and white blood cell count. The comparator was standard care. </p> </section> <section id="CD010130-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD010130-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010130-list-0001"> <li> <p>Number of participants given an antibiotic prescription at the index consultation and within 28 days follow‐up. </p> </li> <li> <p>Number of participants with substantial improvement (including full recovery) within seven days follow‐up. </p> </li> <li> <p>Total mortality within 28 days follow‐up.</p> </li> </ol> </p> </section> <section id="CD010130-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010130-list-0002"> <li> <p>Number of participants in need of a reconsultation within 28 days follow‐up.</p> </li> <li> <p>Number of participants in need of a hospital admission within 28 days follow‐up.</p> </li> <li> <p>Duration of the ARI (e.g. mean or median days with restrictions in daily activities due to the infection). </p> </li> <li> <p>Number of satisfied participants.</p> </li> <li> <p>Number of participants with substantial improvement (including full recovery) within 28 days follow‐up. </p> </li> </ol> </p> <p>As the follow‐up period for specific outcomes may vary between studies, we categorised follow‐up periods as: </p> <p> <ol id="CD010130-list-0003"> <li> <p>0 to 7 days: within 7 days follow‐up.</p> </li> <li> <p>8 to 28 days: within 28 days follow‐up.</p> </li> </ol> </p> </section> </section> </section> <section id="CD010130-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010130-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on 14 June 2022 (2022, Issue 6), MEDLINE (1946 to 14 June 2022), Embase (1974 to 14 June 2022), CINAHL (Cumulative Index to Nursing and Allied Health Literature) (1981 to 14 June 2022), Web of Science (1955 to 15 June 2022), and LILACS (Latin American and Caribbean Health Science Information database) (1982 to 14 June 2022). </p> <p>The search strategy used for CENTRAL and MEDLINE is described in <a href="./appendices#CD010130-sec-0143">Appendix 1</a>. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD010130-bbs2-0086" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Lefebvre 2021</a>). We adapted the search strategy to search Embase (<a href="./appendices#CD010130-sec-0144">Appendix 2</a>), CINAHL (<a href="./appendices#CD010130-sec-0145">Appendix 3</a>), Web of Science (<a href="./appendices#CD010130-sec-0146">Appendix 4</a>), and LILACS (<a href="./appendices#CD010130-sec-0147">Appendix 5</a>). We applied no language or publication type restrictions. </p> </section> <section id="CD010130-sec-0025"> <h4 class="title">Searching other resources</h4> <section id="CD010130-sec-0026"> <h5 class="title">Trials</h5> <p>We searched the trial registries of the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), the EU Clinical Trials Register (<a href="https://www.clinicaltrialsregister.eu/" target="_blank">www.clinicaltrialsregister.eu/</a>), and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>) on 10 December 2021 for completed and ongoing trials.  </p> </section> <section id="CD010130-sec-0027"> <h5 class="title">Correspondence</h5> <p>We contacted experts in the field to identify eligible published, non‐published, or ongoing studies. We also contacted companies that manufacture point‐of‐care biomarker tests (Thermo‐Fisher, Hoffmann‐LaRoche, Orion Diagnostica, Axis‐Shield, Hemocue, and Siemens Diagnostica). </p> </section> <section id="CD010130-sec-0028"> <h5 class="title">Reference lists</h5> <p>We checked the reference lists of included studies.</p> </section> </section> </section> <section id="CD010130-sec-0029"> <h3 class="title" id="CD010130-sec-0029">Data collection and analysis</h3> <section id="CD010130-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SAS and CL) independently assessed the titles and abstracts identified by the searches. We collected and assessed the full‐text copies of potentially eligible articles. Any disagreements were resolved through discussion involving the remaining review authors, when necessary. </p> </section> <section id="CD010130-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SAS, CL) independently extracted data and information on study design from the included trials and entered the information onto a data extraction form. We contacted the trial authors for missing outcome data or trial characteristics as necessary. We extracted the following data. </p> <p> <ol id="CD010130-list-0004"> <li> <p>Trial characteristics: geographic location; unit of randomisation; allocation sequence generation; concealment of allocation; blinding; number of participants; number of intervention arms; length of follow‐up. </p> </li> <li> <p>Participant characteristics: baseline characteristics (mean (or median) age; gender; comorbidities); number of participants randomised to each intervention arm; number of participants completing the trial; inclusion criteria; types of ARIs and duration; exclusion criteria. </p> </li> <li> <p>Intervention characteristics: type of point‐of‐care biomarker and corresponding specified cut‐off values for guidance of antibiotic prescribing, if any. </p> </li> <li> <p>Outcome measures: all available primary and secondary outcome measures specified for this review. </p> </li> </ol> </p> <p>We converted ranking scales on recovery and patient satisfaction to dichotomised outcomes by collapsing response categories when needed in order to make a category of substantially recovered versus not substantially recovered.  </p> </section> <section id="CD010130-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SAS, CL) independently assessed risk of bias of the included studies using the Cochrane risk of bias tool as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010130-bbs2-0076" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). This included assessment of sequence generation, allocation concealment, blinding (participants, personnel, and outcome assessors), incomplete outcome data and selective outcome reporting bias, as well as other sources of bias. We searched for selective outcome reporting by comparing the methods and results section of the study with the trial protocol when available. </p> <p>For cluster‐RCTs, we specifically checked for other sources of bias including selection bias, baseline imbalance between clusters, loss of clusters, and incorrect analysis (<a href="./references#CD010130-bbs2-0077" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>).  </p> </section> <section id="CD010130-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <section id="CD010130-sec-0034"> <h5 class="title">Dichotomous data</h5> <p>We reported the treatment effect as a risk ratio (RR) with 95% confidence intervals (CIs) for each dichotomised outcome. We estimated the number needed to test (NNT) by using assumed control risk (ACR) calculated from the control groups event rate for C‐reactive protein point‐of‐care tests (<a href="./references#CD010130-bbs2-0077" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). NNT indicates the number of patients needed to test with a point‐of‐care test to save one patient given an antibiotic prescription. When we could not pool results, we presented them narratively. We did not carry out NNT for procalcitonin, as only one study was included. </p> </section> <section id="CD010130-sec-0035"> <h5 class="title">Continuous data</h5> <p>For outcomes presented in other forms (e.g. reported as medians, quartiles, etc.) or without consistent statistical information (e.g. standard deviations (SDs), or number of participants), we presented them narratively and included these data in Additional tables (<a href="#CD010130-tbl-0004">Table 2</a>; <a href="#CD010130-tbl-0005">Table 3</a>). </p> <div class="table" id="CD010130-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">C‐reactive protein ‐ duration of symptoms</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Mean (SD)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Median (IQR)</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 (14 to 28)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 (14 to 28)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.5 (9.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.8 (9.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.5 (9.5 to 28)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 (13.5 to &gt; 28)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinosinusitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.3 (9.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6 (9.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (10 to 28)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (7 to &gt; 28)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ARTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (4 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (4 to7)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (3 to 9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 9)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>URTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (3 to 8)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 9)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: ARI: acute respiratory tract infection (LRTI + URTI); IQR: interquartile range; LRTI: lower respiratory tract infection; SD: standard deviation; URTI: upper respiratory tract infection </p> <p><sup>a</sup>Reported as time to full recovery.<br/><sup>b</sup>Reported as time to resolution of symptoms.<br/><sup>c</sup>Reported as resolution of moderately bad or worse symptoms. </p> </div> </div> <div class="table" id="CD010130-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Procalcitonin ‐ duration of symptoms</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Mean (SD)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Median (IQR)</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: IQR: interquartile range; SD: standard deviation</p> <p><sup>a</sup>Based on total symptoms score reported by participants within 28 days. </p> </div> </div> <p>We converted ranking scales on recovery and patient satisfaction to dichotomised outcomes by collapsing response categories when needed in order to make a category of substantially recovered versus not substantially recovered. </p> </section> </section> <section id="CD010130-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant. For cluster‐RCTs, we adjusted the unit of analysis by calculating the design effect to modify sample sizes using intraclass correlation coefficient (ICC) (<a href="./references#CD010130-bbs2-0077" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>).  </p> <p>We analysed multi‐arm trials by combining groups to create a single pair‐wise comparison. We included one factorial trial, and extracted data by including all participants who had received a test compared with all participants who did not receive a test. One trial was a three‐armed study, where one group received both a point‐of‐care test and a lung ultrasound scan. We chose not to include this specific group, as this had too much influence on the antibiotic treatment being given. </p> </section> <section id="CD010130-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial authors to obtain any missing data from the included studies. Where possible, we extracted data to permit an intention‐to‐treat (ITT) analysis. We did a worst‐case scenario sensitivity analysis considering missing outcome data as treatment failures in the intervention group and treatment successes in the control group, and not missing at random. </p> </section> <section id="CD010130-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>We investigated heterogeneity using the I² statistic, employing the following cut‐off values based on <a href="./references#CD010130-bbs2-0077" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>: </p> <p> <ol id="CD010130-list-0005"> <li> <p>30% to 60%: moderate heterogeneity;</p> </li> <li> <p>50% to 90%: substantial heterogeneity;</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ol> </p> <p>We interpreted the overlapping cut‐off values and the importance of the observed heterogeneity based on the magnitude and direction of effects, and the strength of evidence for heterogeneity. </p> </section> <section id="CD010130-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>We carried out a funnel plot to assess possible missing results for our primary outcome, which was the number of patients given an antibiotic prescription at index consultation. </p> </section> <section id="CD010130-sec-0040"> <h4 class="title">Data synthesis</h4> <p>When possible, we calculated a weighted estimate for the selected outcomes by means of a random‐effects meta‐analysis using Review Manager Web software (<a href="./references#CD010130-bbs2-0102" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>). </p> <p>We handled data from studies on C‐reactive protein point‐of‐care test separate from procalcitonin point‐of‐care test, as these two types of tests are two different interventions. They differ in type of biomarker, amount of time used for analysis (2 to 3 minutes versus 20 minutes), and therefore needed to be interpreted differently. We carried out a meta‐analysis on studies that evaluated C‐reactive protein as point‐of‐care test in primary care, but did not carry out a meta‐analysis on procalcitonin as point‐of‐care test, as only one study was included. </p> <p>We extracted and used ICCs for cluster‐RCTs to avoid a unit of analysis error by calculating the design effect to modify sample sizes. </p> </section> <section id="CD010130-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We grouped results from studies according to methodological and clinical aspects.</p> <section id="CD010130-sec-0042"> <h5 class="title">Planned subgroup analysis</h5> <p>We planned the following subgroup analyses as predefined in the study protocol.</p> <p> <ol id="CD010130-list-0006"> <li> <p>Serious infections (e.g. pneumonia) and less serious infections (e.g. common colds and bronchitis). </p> </li> <li> <p>Children and adults.</p> </li> <li> <p>Type of point‐of‐care test.</p> </li> <li> <p>Trials with low risk of bias and high risk.</p> </li> <li> <p>Cluster‐RCTs and individually randomised studies.</p> </li> </ol> </p> <p>To examine differences amongst subgroups, we performed a standard test for heterogeneity across subgroups. </p> </section> <section id="CD010130-sec-0043"> <h5 class="title">Considerations for subgroup analysis</h5> <section id="CD010130-sec-0044"> <h6 class="title">Serious infections and less serious infections</h6> <p>There might be differences in effect estimates between people with severe and people with less severe infection. </p> </section> <section id="CD010130-sec-0045"> <h6 class="title">Children and adults</h6> <p>There might be a biological variation between adults and children regarding the inflammation and immune system response.  </p> </section> <section id="CD010130-sec-0046"> <h6 class="title">Type of point‐of‐care test</h6> <p>The different types of point‐of‐care test (C‐reactive protein versus procalcitonin versus leucocytes) are different in many aspects. They measure different biomarkers and have different cut‐off values and turnaround times (C‐reactive protein takes 2 to 3 minutes, whilst procalcitonin takes up to 20 minutes). It was therefore essential to keep the type of biomarkers separate in the meta‐analysis, but also to check for possible subgroup differences.   </p> </section> <section id="CD010130-sec-0047"> <h6 class="title">Trials with low risk of bias and high risk of bias</h6> <p>Trials with high risk of bias may overestimate the true effect estimate. </p> </section> <section id="CD010130-sec-0048"> <h6 class="title">Cluster‐RCTs and individually randomised studies</h6> <p>Although we modified sample sizes for the cluster‐RCTs by using the ICCs to avoid unit of analysis error, we also planned to carry out subgroup analysis on cluster‐RCTs and individually randomised studies. This is particularly of interest, as cluster‐RCTs have a tendency to overestimate the true effect estimate. </p> </section> </section> <section id="CD010130-sec-0049"> <h5 class="title">Reasons for omitted planned subgroup analysis</h5> <section id="CD010130-sec-0050"> <h6 class="title">Serious infections and less serious infections</h6> <p>Unfortunately the subgroup analysis on serious infections and less serious infections was not possible, as no studies investigated this. However, we did perform a subgroup analysis on similar subgroups between upper respiratory tract infections and lower respiratory tract infections. </p> </section> <section id="CD010130-sec-0051"> <h6 class="title">Type of point‐of‐care test</h6> <p>A subgroup analysis on different types of point‐of‐care test was not possible, as most studies investigated C‐reactive protein point‐of‐care‐tests, and only one study investigated procalcitonin as a point‐of‐care test in the primary care setting. </p> </section> <section id="CD010130-sec-0052"> <h6 class="title">Trials with low risk of bias and high risk of bias</h6> <p>All trials were non‐blinded, thereby introducing a high risk of bias, thus we omitted the pre‐planned subgroup analysis on trials with low risk of bias and high risk of bias. </p> </section> </section> </section> <section id="CD010130-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <section id="CD010130-sec-0054"> <h5 class="title">Planned sensitivity analysis</h5> <p>A per‐protocol sensitivity analysis for our primary outcomes using a fixed‐effect model was planned but was not carried out due to substantial heterogeneity. We carried out a worst‐case sensitivity analysis, considering missing outcome data as treatment failures in the intervention group and treatment successes in the control group. </p> </section> <section id="CD010130-sec-0055"> <h5 class="title">Post hoc sensitivity analysis</h5> <p>As follow‐up time on specific outcomes varied between studies, we had to specify the follow‐up time, as this was not prespecified in the protocol or the original review. We carried out a sensitivity analysis to investigate whether our new specified follow‐up times would affect which studies to include from the original review and the new search.  </p> <p>To assess the considerable heterogeneity and the subgroup differences detected, we performed a post hoc sensitivity analysis of the newer studies separately, as these studies used specific guidance on antibiotic prescription if C‐reactive protein levels were &lt; 20 mg/L. </p> </section> </section> <section id="CD010130-sec-0056"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created two summary of findings tables, one for each type of biomarker point‐of‐care‐test: procalcitonin and C‐reactive protein (<a href="./full#CD010130-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD010130-tbl-0002">summary of findings Table 2</a>). Both summary of findings tables used the following outcomes: number of participants given an antibiotic prescription at index consultation; number of participants given an antibiotic prescription within 28 days follow‐up; participant recovery within seven days follow‐up; total mortality within 28 days follow‐up; number of participants in need of a hospital admission within 28 days follow‐up; and participant recovery within 28 days follow‐up. We used the five GRADE domains (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the evidence as it relates to the studies which contribute data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD010130-bbs2-0049" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">Atkins 2004</a>; <a href="./references#CD010130-bbs2-0077" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). We assessed the certainty of the evidence for each outcome as high, moderate, low, or very low. We used the methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010130-bbs2-0077" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>), employing GRADEpro GDT software (<a href="./references#CD010130-bbs2-0073" title="GRADEpro GDT. Version accessed 2 January 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). We justified all decisions to down‐ or upgrade the certainty of the evidence using footnotes, and made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010130-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010130-sec-0057"></div> <section id="CD010130-sec-0058"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010130-sec-0174" title="">Characteristics of included studies</a>, <a href="./references#CD010130-sec-0175" title="">Characteristics of excluded studies</a>, and <a href="./references#CD010130-sec-0176" title="">Characteristics of ongoing studies</a>. </p> <section id="CD010130-sec-0059"> <h4 class="title">Results of the search</h4> <p>A PRISMA flow diagram is presented as <a href="#CD010130-fig-0001">Figure 1</a>. We found 13 eligible studies, with 10,535 participants recruited from primary care settings, of which 2335 were children and 8200 were adults. Diagnoses were predominately lower ARIs (75%) (<a href="#CD010130-tbl-0006">Table 4</a>; <a href="#CD010130-tbl-0007">Table 5</a>). Twelve studies investigated the point‐of‐care biomarker C‐reactive protein (10,218 participants), and one trial investigated the point‐of‐care biomarker procalcitonin (317 participants). We found no studies comparing different kinds of biomarkers. </p> <div class="figure" id="CD010130-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010130-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <div class="table" id="CD010130-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">C‐reactive protein ‐ baseline characteristics of included participantsa </span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Parameter</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Studies</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein group</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control group</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age, mean (SD)<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.1 (13.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.4 (13.1)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gender (female) % (n/N)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61.0 (4597/7542)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.6 (4258/7030)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Current smokers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.5 (1283/3020)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.9 (1173/2675)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comorbidity<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.3 (1014/3139)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.7 (862/2806)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Primary diagnosis</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclassified upper ARI<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.5 (499/2325)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.1 (446/2118)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.3 (13/394)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5 (17/374)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Common cold</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9 (15/108)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.8 (22/131)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinosinusitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.3 (143/523)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.2 (137/502)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total upper ARI<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.7 (670/2956)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.6 (622/2752)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.7 (16/209)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.4 (30/209)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI/acute cough</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.3 (2364/3183)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.5 (2173/2956)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bronchitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.9 (41/108)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.1 (42/131)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbations of COPD or asthma</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.8 (341/433)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.7 (335/437)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total lower ARI<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.8 (2446/3183)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70.5 (2271/2956)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3 (9/108)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.2 (12/131)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other respiratory diseases</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3 (67/502)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.1 (66/505)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: ARI: acute respiratory infection; COPD: chronic obstructive pulmonary disease; LRTI: lower respiratory tract infection; SD: standard deviation </p> <p><sup>a</sup>Crude numbers provided from all studies regardless of design.<br/><sup>b</sup><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> reported the median age: 50 (range 18 to 83) in the C‐reactive protein arm versus 44 (18 to 82) in the control arm. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> reported median age 16 (8 to 39) in the C‐reactive protein arm versus 15 (8 to 41) in the control arm. <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> reported the median age 3 (0 to 11) in the C‐reactive protein arm versus 2 (0 to 11) in the control arm.<br/><sup>c</sup>COPD; asthma; heart disease; diabetes mellitus.<br/><sup>d</sup>Acute respiratory infection.<br/><sup>e</sup>Any upper acute respiratory infections.<br/><sup>f</sup>Any lower acute respiratory infections. </p> </div> </div> <div class="table" id="CD010130-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Procalcitonin ‐ baseline characteristics of included participants</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Parameter</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control group</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age, mean (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 (18.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 (18.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gender (female) % (n/N)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 (126/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 (65/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Current smokers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 (44/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (31/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comorbidity<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.5 (75/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.6 (52/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Primary diagnosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclassified upper ARI<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Common cold</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinosinusitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total upper ARI<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI/acute cough</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (195/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (122/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbations of COPD or asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total lower ARI<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other respiratory diseases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: ARI: acute respiratory infection; COPD: chronic obstructive pulmonary disease; LRTI: lower respiratory tract infection; SD: standard deviation </p> <p><sup>a</sup>COPD; asthma; heart disease; diabetes.<br/><sup>b</sup>Acute respiratory infections.<br/><sup>c</sup>Any upper respiratory infection.<br/><sup>d</sup>Any lower acute respiratory infection. </p> </div> </div> <p>We identified five ongoing studies (<a href="./references#CD010130-bbs2-0039" title="ISRCTN01559032. Respiratory tract infections in primary care [Converting habits of antibiotic prescribing for respiratory tract infections in German primary care - the cluster-randomized controlled CHANGE-2 trial]. www.isrctn.com/ISRCTN01559032 (first received 24 August 2012). ">ISRCTN01559032</a>; <a href="./references#CD010130-bbs2-0040" title="NCT03540706. Impact of the use of CRP on the prescription of antibiotics in General Practitioners (VIP). clinicaltrials.gov/ct2/show/NCT03540706 (first received 30 May 2018). ">NCT03540706</a>; <a href="./references#CD010130-bbs2-0041" title="NCT03855215. Implementation of CRP point-of-care testing in primary care to improve antibiotic targeting in respiratory illness (ICAT). clinicaltrials.gov/ct2/show/study/NCT03855215 (first received 26 February 2019). ">NCT03855215</a>; <a href="./references#CD010130-bbs2-0042" title="NCT03931577. Effectiveness of improving diagnostic and communication skills on antibiotic prescribing appropriateness in acute cough (ISAAC-CAT). clinicaltrials.gov/ct2/show/NCT03931577 (first received 30 April 2019). ">NCT03931577</a>; <a href="./references#CD010130-bbs2-0043" title="NCT04216277. The procalcitonin guided antibiotics in respiratory infections in General Practice (PARI). clinicaltrials.gov/ct2/show/NCT04216277 (first received 2 January 2020). ">NCT04216277</a>). We will incorporate data from these studies when results are available. </p> </section> <section id="CD010130-sec-0060"> <h4 class="title">Included studies</h4> <p>The 13 included studies were conducted between 1995 and 2021 in Europe (<a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>), Russia (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>), and Asia (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>). Six studies were individually randomised trials (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>), and seven were cluster‐RCTs (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> was originally designed as a cluster‐RCT, but due to insufficient uptake, the study set‐up was changed to include individually randomised participants. We chose to classify and analyse data from <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> as a cluster‐RCT, as most participants were cluster‐randomised (99 children (32%) were individually randomised, whilst 210 children were cluster randomised). </p> <section id="CD010130-sec-0061"> <h5 class="title">Inclusion criteria</h5> <p>Inclusion criteria differed amongst studies. <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>, and to a lesser extent <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> and <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>, used broad inclusion criteria, whilst <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>, <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>, <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>, <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>, <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>, and <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> used more narrow diagnostic criteria for lower or upper ARIs, or both. <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> included participants with fever in general, but provided detailed information on ARIs.   </p> </section> <section id="CD010130-sec-0062"> <h5 class="title">Population </h5> <p>Participants differed amongst studies. <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a> included patients &gt; 40 years of age with chronic obstructive pulmonary disease (COPD). <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a> included participants from nursing homes. Four studies included children (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). Only <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> included children alone (aged 3 months to 12 years). The remaining three studies included either all age groups or from 1 to 65 years of age. </p> </section> <section id="CD010130-sec-0063"> <h5 class="title">Setting</h5> <p>All included studies were conducted in a primary healthcare setting. Nine studies included participants from primary care practices (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>), whilst the remaining four studies included participants from other primary healthcare sectors (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> included participants from nine public primary care units and one outpatient department in Myanmar. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> included participants from nine primary healthcare centres and one outpatient clinic in Vietnam. The outpatient clinics were manned by nurses and medical doctors, and the clinics form part of the primary healthcare sector in these countries. <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> included participants in an "out of office hours" facility staffed by general practitioners. <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a> included participants from nursing homes.  </p> </section> <section id="CD010130-sec-0064"> <h5 class="title">C‐reactive protein cut‐off values</h5> <p>We noted appreciable differences between the C‐reactive protein cut‐off values applied to guide antibiotic treatment, which ranged from vague indications of such values to specific numeric recommendations for initiating or withholding antibiotic treatment, or both (<a href="#CD010130-tbl-0008">Table 6</a>). Test results were made available to the physicians as part of the initial clinical assessment in most studies, except for <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>, which only made results available to physicians after the initial clinical decision. <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> communicated results of C‐reactive protein measurements to the healthcare provider as low C‐reactive protein or high C‐reactive protein using cut‐off thresholds of either 20 mg/L (group A) or 40 mg/L (group B). The exact set‐up was left to the participating physician to accommodate in <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>. The treating physician could overrule C‐reactive protein guidance in all trials.   </p> <div class="table" id="CD010130-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">C‐reactive protein ‐ inclusion criteria and C‐reactive protein algorithms of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomisation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Inclusion criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Algorithm used*</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with subjective complaint of i) pneumonia, bronchitis, or asthma (no further description); or ii) 1 of the following symptoms: cough, shortness of breath, chest pain on deep inspiration or when coughing </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of illness <b>&lt; 24 hours</b> and C‐reactive protein levels lower than 50 mg/L: no change in clinical decision. C‐reactive protein levels &gt; 50 mg/L: immediate antibiotic prescribing was recommended </p> <p>Duration of illness <b>1 to 6 days</b> and C‐reactive protein levels &lt; 11 mg/L: no antibiotics recommended. Participants with C‐reactive protein levels between 11 and 49 mg/L: no change in clinical decision. C‐reactive protein levels &gt; 50 mg/L: immediate antibiotic prescribing was recommended </p> <p>Duration of illness <b>&gt; 7 days</b> and C‐reactive protein levels &lt; 11 mg/L: no antibiotics recommended. Participants with C‐reactive protein levels between 11 and 24 mg/L: no change in clinical decision. C‐reactive protein levels &gt; 25 mg/L: immediate antibiotic prescribing was recommended </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients with a respiratory infection (no further description)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Strict cut‐off values were not given, but information was provided that a normal C‐reactive protein level was <b>&lt; 10 mg/L</b> and that C‐reactive protein levels <b>&lt; 50 mg/L</b> were seldom the result of bacterial infection. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with suspected LRTI (cough &lt; 4 weeks AND</p> <p>1 focal sign/symptom (shortness of breath, wheezing, chest pain, auscultation abnormalities) AND </p> <p>1 systemic sign/symptom (fever &gt; 38 °C, perspiring, headache, myalgia, feeling generally unwell) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 20 mg/L</b>: pneumonia extremely unlikely and antibiotic prescribing discouraged </p> <p>C‐reactive protein levels between <b>20 and 50 mg/L</b>: pneumonia very unlikely </p> <p>C‐reactive protein levels between <b>50 and 100 mg/L</b>: clear infection. Acute bronchitis most likely, possible pneumonia </p> <p>C‐reactive protein <b>&gt; 100 mg/L</b>: severe infection. Pneumonia more likely. Immediate antibiotic prescribing was recommended. </p> <p>C‐reactive protein levels between <b>20 and 99 mg/L</b>: consider delayed prescribing </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with:</p> <p>i) LRTI (cough &lt; 4 weeks) AND</p> <p>1 focal sign/symptom (shortness of breath, wheezing, chest pain, auscultation abnormalities) AND </p> <p>1 systemic sign/symptom (fever &gt; 38 °C, perspiring, headache, myalgia, feeling generally unwell) </p> <p>ii) Rhinosinusitis &lt; 4 weeks AND</p> <p>1 symptom (history of rhinorrhoea, blocked nose)</p> <p>1 symptom or sign (purulent rhinorrhoea, unilateral facial pain, headache, teeth pain, pain when chewing, maxillary/frontal pain when bending over, worsening of symptoms after initial improvement) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 20 mg/L</b>: bacterial infection was considered highly unlikely and antibiotic prescribing was discouraged </p> <p>C‐reactive protein levels <b>&gt; 100 mg/L</b>: bacterial infection was considered likely and immediate antibiotic prescribing was recommended </p> <p>C‐reactive protein levels between <b>20 and 99 mg/L</b>: consider delayed prescribing </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with:</p> <p>i) LRTI/acute cough (up to 28 days' duration) as the main symptom, or alternatively where cough was not the most prominent symptom (e.g. fever, malaise), but where the clinician considered acute LRTI to be the main diagnosis. Pneumonia was not an exclusion criterion. </p> <p>ii) URTI: as with LRTI, but judged by the physician to be another acute respiratory infection (sore throat, otitis media, sinusitis, influenza and/or coryzal illness) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b>: self‐limiting ARI, withhold antibiotics </p> <p>C‐reactive protein <b>21 to 50 mg/L</b>: majority of participants have self‐limiting ARI, withhold antibiotics in most cases </p> <p>C‐reactive protein <b>51 to 99 mg/L</b>: withhold antibiotics in the majority of cases and consider delayed antibiotics in the minority of cases </p> <p>C‐reactive protein <b>≥ 100 mg/L</b>: severe infection, prescribe antibiotics </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with LRTI/acute cough (including acute bronchitis, pneumonia, and infectious exacerbations of COPD or asthma) for less than 28 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>&lt; 20 mg/L</b>: antibiotics usually not needed </p> <p>C‐reactive protein <b>&gt; 50 mg/L</b>: antibiotic prescribing could be indicated taking into account the duration of illness </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients aged 1 to 65 years of age presenting with non‐severe acute respiratory tract infection with at least 1 focal and 1 systemic sign or symptom by the treating physician.  </p> <p>Focal signs; cough, rhinitis, pharyngitis, shortness of breath, wheezing, chest pain, and auscultation abnormalities  </p> <p>Systemic signs and symptoms; fever, perspiration, headache, myalgia, and feeling generally unwell </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b> for participants aged 6 to 65 years: prescription of antibiotics not recommended  </p> <p>C‐reactive protein <b>≥ 100 mg/L</b> for participants aged 6 to 65 years: should generally receive antibiotics, and hospital referral should be considered </p> <p> </p> <p>C‐reactive protein <b>≤ 10 mg/L</b> for children aged 1 to 5 years: prescription of antibiotics not recommended </p> <p>C‐reactive protein <b>≥ 50 mg/L</b> for children aged 1 to 5 years: should generally receive antibiotics, and hospital referral should be considered.  </p> <p> </p> <p>Between these thresholds no specific recommendation was given, and clinicians were advised to use their clinical discretion. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children between 3 months and 12 years of age with suspicion of lower respiratory tract infection; acute cough &lt; 21 days; reported fever &gt; 38 °C &lt; 5 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 10 mg/L</b> make pneumonia less likely, but should not be used to exclude pneumonia when the GP finds the child ill, or when duration of symptoms is &lt; 6 hours </p> <p>C‐reactive protein between <b>10 mg/L and 100 mg/L</b>, the likelihood of pneumonia increases with increasing CRP levels </p> <p>C‐reactive protein levels<b>&gt; 100 mg/L</b> make pneumonia much more likely; however, such levels can also be caused by viral infections </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients aged 1 year or older with:</p> <p>a documented fever (defined as a tympanic temperature of &gt; 37.5 °C according to WHO standards) OR  </p> <p>a chief complaint of fever (&lt; 14 days), regardless of previous antibiotic intake and comorbidity other than malignancies </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group A: the result of CRP measurement was communicated to the healthcare provider as low CRP or high CRP using cut‐off thresholds of <b>20 mg/L</b> </p> <p> </p> <p>Intervention group B: the result of CRP measurement was communicated to the healthcare provider as low CRP or high CRP using cut‐off thresholds of<b>40 mg/L</b> </p> <p> </p> <p>If CRP measurement was <b>low</b>, antibiotics should be refrained from if no danger signs were present.  </p> <p>If CRP measurement was <b>high</b>, antibiotics should be considered on the basis of clinical judgement. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients aged 40 years or older and diagnosis of COPD in their primary care clinical record; presenting with an acute exacerbation of COPD with at least 1 of AECOPD criteria (increased dyspnoea, increased sputum volume, increased sputum purulence), between 24 hours and 21 days duration </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b>: antibiotics are unlikely to be beneficial and should usually not be prescribed </p> <p>C‐reactive protein <b>20 to 40 mg/L</b>: antibiotics may be beneficial, mainly if purulent sputum is present </p> <p>C‐reactive protein <b>≥ 40 mg/L</b>: antibiotics are likely to be beneficial </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with:</p> <p>i) LRTI/acute cough (up to 28 days duration) as the main symptom, or alternatively where cough was not the most prominent symptom (e.g. fever, malaise), but where the clinician considered acute LRTI to be the main diagnosis. Pneumonia was not an exclusion criterion. </p> <p>ii) URTI: as with LRTI, but judged by the physician to be another acute respiratory infection (sore throat, otitis media, sinusitis, influenza and/or coryzal illness) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b>: self‐limiting ARI, withhold antibiotics </p> <p>C‐reactive protein <b>21 to 50 mg/L</b>: the majority of patients have self‐limiting ARI, withhold antibiotics in most cases </p> <p>C‐reactive protein <b>51 to 99 mg/L</b>: withhold antibiotics in the majority of cases and consider delayed antibiotics in the minority of cases </p> <p>C‐reactive protein <b>≥ 100 mg/L</b>: severe infection, prescribe antibiotics </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All somatic, psychogeriatric, and short‐stay (geriatric rehabilitation and short‐term residential care) nursing home residents with a suspected LRTI, according to their physician’s assessment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 20 mg/L</b>: self‐limiting LRTI. Assessment of signs, symptoms, risk factors, and CRP is important. Withhold antibiotics in most cases </p> <p>C‐reactive protein levels <b>20 to 60 mg/L</b>: assessment of signs, symptoms, risk factors, and CRP is important. Withhold antibiotics in most cases </p> <p>C‐reactive protein levels <b>&gt; 60 mg/L</b>: severe infection, prescribe antibiotics </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: AECOPD: acute exacerbations of chronic obstructive pulmonary disease; ARI: acute respiratory infection; COPD: chronic obstructive pulmonary disease; CRP: C‐reactive protein; GP: general practitioner; LRTI: lower respiratory tract infection; URTI: upper respiratory tract infection; WHO: World Health Organization </p> <p>*All studies stated that physicians could deviate from the algorithm at any time.</p> </div> </div> </section> <section id="CD010130-sec-0065"> <h5 class="title">Procalcitonin</h5> <p>One study investigated the use of procalcitonin as a point‐of‐care biomarker in ARI in primary care (<a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>). The cut‐off value of procalcitonin was 0.25 μg/L (<a href="#CD010130-tbl-0009">Table 7</a>). The point‐of‐care test provided results in 20 minutes. The study is described in <a href="./references#CD010130-sec-0174" title="">Characteristics of included studies</a>. </p> <div class="table" id="CD010130-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Procalcitonin ‐ inclusion criteria and procalcitonin algorithms of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomisation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Inclusion criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Algorithm used</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with acute cough &lt; 21 days and at least 1 of the following signs/symptoms: history of fever for more than 4 days; dyspnoea; tachypnoea (&gt; 22 cycles per minute); abnormal focal findings upon lung auscultation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Procalcitonin ≥ 0.25 μg/L: antibiotics prescribing recommended</p> <p> </p> <p>Antibiotic choice, dose, and duration were left to the discretion of the primary care physician. The physician could also order further diagnostic tests. </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010130-sec-0066"> <h5 class="title">Outcome assessment</h5> <p>Outcome assessment was based on medical records regarding the number of participants given an antibiotic prescription, although <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a> also used participant‐reported antibiotic usage. Secondary outcomes such as clinical recovery were reported by participants using diaries and questionnaires, or during follow‐up visits at the clinics (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). </p> </section> <section id="CD010130-sec-0067"> <h5 class="title">Other aspects</h5> <p>One study was terminated by the principal investigator after one year without reaching the target inclusion rate due to an interim analysis that showed no difference between groups and because of lack of interest from the participating general practitioners (<a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> was a 12‐month follow‐up of the original study, <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>, and included participants from the same practices. The study noted that C‐reactive protein testing was seldom used at 12‐month follow‐up (5.77% in the intervention group) (<a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>). One study reported frequent violation to adherence to protocol (30 out of 165 participants in the control group had C‐reactive protein measurements) (<a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). Two studies received economic funding from manufacturers of C‐reactive protein point‐of‐care tests (<a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). Three studies received test kits or reagents, or both, for the study (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>). On‐site training in C‐reactive protein devices was performed by manufacturers in four studies (<a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>). </p> </section> <section id="CD010130-sec-0068"> <h5 class="title">Additional data</h5> <p>We contacted a total of six study authors for additional details. We obtained raw data from <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> to calculate the number of participants with substantial improvement and to differentiate between children and adults. <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> provided specific details and raw data to differentiate participants with symptoms of ARIs to permit inclusion in the meta‐analysis. </p> </section> </section> <section id="CD010130-sec-0069"> <h4 class="title">Excluded studies</h4> <p>We excluded one study that used an electronic algorithm in combination with a specific point‐of‐care test (C‐reactive protein test) (<a href="./references#CD010130-bbs2-0025" title="KeitelK , KagoroF , SamakaJ , MasimbaJ , SaidZ , TembaH , et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): a randomized, controlled non-inferiority trial. PLOS Medicine2017;23(14):e1002411. [DOI: 10.1371/journal.pmed.1002411]">Keitel 2017</a>), and one study that used a specific antigen test (<a href="./references#CD010130-bbs2-0026" title="LittleP , HobbsR , MooreM , MantD , WilliamsonI . PRImary Care Streptococcal Management Study (PRISM): in vitro study, diagnostic cohorts, and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study. Health Technology Assessement2014;18(6):1-101. [DOI: 10.3310/hta18060]">Little 2014</a>).  </p> <p>Five studies were not conducted in a primary care setting (<a href="./references#CD010130-bbs2-0014" title="AmeyawE , NguahSB , AnsongD , PageI , GuillermM , BatesI . The outcome of a test-treat package versus routine outpatient care for Ghanaian children with fever: a pragmatic randomized control trial. Malaria Journal2014;13:461. [DOI: 10.1186/1475-2875-13-461]">Ameyaw 2014</a>; <a href="./references#CD010130-bbs2-0022" title="HuangDT , YealyDM , FilbinMR , BrownAM , ChangCH , DoiY , et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. New England Journal of Medicine2018;379(3):236-49. [DOI: 10.1056/NEJMoa1802670]">Huang 2018</a>; <a href="./references#CD010130-bbs2-0023" title="IsaHM , MohroofiAD , AlkhanFN , HasanAZ , AlkubisiMM , AlhewaizemSS , et al. C-reactive protein levels in children with acute bronchiolitis. International Journal of Pediatrics 23 May 2022;eCollection:1311936. [DOI: 10.1155/2022/1311936]">Isa 2022</a>; <a href="./references#CD010130-bbs2-0031" title="MontassierE , JavaudinF , MoustafaF , NandjouD , MaignanM , HardouinJB , et al. Guideline-based clinical assessment versus procalcitonin-guided antibiotic use in pneumonia: a pragmatic randomized trial. Annals of Emergency Medicine2019;74(4):580-91. [DOI: 10.1016/j.annemergmed.2019.02.025.]">Montassier 2019</a>; <a href="./references#CD010130-bbs2-0034" title="Schechter-PerkinsEM , MitchellPM , NelsonKP , LiuJH , ShannonA , AhernJ , et al. Point-of-care influenza testing does not significantly shorten time to disposition among patients with an influenza-like illness. American Journal of Emergency Medicine2019;37(5):873-8. [DOI: 10.1016/j.ajem.2018.08.005.]">Schechter‐Perkins 2019</a>). We excluded one study that did not assess a point‐of‐care test to guide antibiotic treatment decisions (<a href="./references#CD010130-bbs2-0028" title="MannD , HessR , McGinnT , RichardsonS , JonesS , PalmisanoJ , et al. Impact of clinical decision support on antibiotic prescribing for acute respiratory infections: a cluster randomized implementation trial. Journal of General Internal Medicine2020;35:788-95. [DOI: 10.1007/s11606-020-06096-3]">Mann 2020</a>), but used clinical decision support to guide antibiotic decisions.  </p> <p>We excluded seven studies that were not RCTs (<a href="./references#CD010130-bbs2-0018" title="deLusignanS , HoangU , LiyanageH , TripathyM , YonovaI , ByfordR , et al. Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study. British Journal of General Practice2020;70(697):e555-62. [DOI: 10.3399/bjgp20X710897]">de Lusignan 2020</a>; <a href="./references#CD010130-bbs2-0019" title="EleyCV , SharmaA , LeeH , CharlettA , OwensR , McNultyCA . Effects of primary care C-reactive protein point-of-care testing on antibiotic prescribing by general practice staff: pragmatic randomised controlled trial, England, 2016 and 2017. Euro Surveillance2020;25(44):1-11. [DOI: 10.2807/1560-7917.ES.2020.25.44.1900408]">Eley 2020</a>; <a href="./references#CD010130-bbs2-0020" title="FioreD . Procalcitonin to guide antibiotic therapy for acute respiratory infections. Internal Medicine Alert2017;39:1-2. ">Fiore 2017</a>; <a href="./references#CD010130-bbs2-0029" title="MeiliM , KutzA , BrielM , Christ-CrainM , BucherHC , MuellerB , et al. Infection biomarkers in primary care patients with acute respiratory tract infections - comparison of procalcitonin and C-reactive protein. BMC Pulmonary Medicine2016;16:Article number: 43. [DOI: 10.1186/s12890-016-0206-4]">Meili 2016</a>; <a href="./references#CD010130-bbs2-0030" title="MinnaardMC , vande PolAC , HopstakenRM , vanDelftS , BroekhuizenBD , VerheijTJ , et al. C-reactive protein point-of-care testing and associated antibiotic prescribing. Family Practice2016;33(4):408-13. [DOI: 10.1093/fampra/cmw039]">Minnaard 2016</a>; <a href="./references#CD010130-bbs2-0032" title="OppongR , SmithRD , LittleP , VerheijT , ButlerCC , GoossensH , et al. Cost-effectiveness of internet-based training for primary care clinicians on antibiotic prescribing for acute respiratory tract infections in Europe. Journal of Antimicrobial Chemotherapy2018;17(11):3189-98. [DOI: 10.1093/jac/dky309.]">Oppong 2018</a>; <a href="./references#CD010130-bbs2-0035" title="StannardD . Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Critical Care Nurse2014;34(2):75-6. [DOI: 10.4037/ccn2014559]">Stannard 2014</a>). </p> <p>We contacted three trial authors to obtain additional details on ARIs, as they included acutely ill participants or participants with fever in general (<a href="./references#CD010130-bbs2-0033" title="RebnordIK , SandvikH , MjelleAB , HunskaarS . Out-of-hours antibiotic prescription after screening with C reactive protein: a randomised controlled study. BMJ Open2016;6(5):e011231. [DOI: 10.1136/bmjopen-2016-011231]">Rebnord 2016a</a>; <a href="./references#CD010130-bbs2-0037" title="Van den BruelA , JonesC , ThompsonM , MantD . C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Archive of Diseases in Childhood2016;101(4):382-5. [DOI: 10.1136/archdischild-2015-309228]">Van den Bruel 2016</a>; <a href="./references#CD010130-bbs2-0038" title="LemiengreMB , VerbakelJY , ColmanR , De BurghgraeveT , BuntinxF , AertgeertsB , et al. Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions. British Journal of General Practice2018;68(668):e204-10. LemiengreMB , VerbakelJY , ColmanR , Van RoyK , De BurghgraeveT , BuntinxF , et al. Point-of-care CRP matters: normal CRP levels reduce immediate antibiotic prescribing for acutely ill children in primary care: a cluster randomized controlled trial. Scandinavian Journal of Primary Health Care 2018;36(4):423-36. [DOI: 10.1080/02813432.2018.1529900]VerbakelJY , LemiengreMB , De BurghgraeveT , De SutterA , AertgeertsB , ShinkinsB , et al. Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial. BMC Medicine2016;14(1):131. [DOI: 10.1186/s12916-016-0679-2.]">Verbakel 2016</a>). Unfortunately, data regarding specific ARI diagnoses or symptoms were not registered or retrievable, resulting in exclusion of these studies. </p> </section> </section> <section id="CD010130-sec-0070"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the risk of bias for each study and individual outcomes. The risk of bias assessment is presented graphically in <a href="#CD010130-fig-0002">Figure 2</a> and summarised in <a href="#CD010130-fig-0003">Figure 3</a>. For further information on included studies, see <a href="./references#CD010130-sec-0174" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD010130-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010130-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010130-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010130-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010130-sec-0071"> <h4 class="title">Allocation</h4> <p>The cluster‐RCTs used computer randomisation programs to allocate practices to the intervention or control arms (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). The individually randomised studies by <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>, <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>, and <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> used sequentially numbered, opaque, sealed envelopes that were opened on site after participant enrolment. <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a> also had the envelopes prepared in different block sizes by an independent research team. <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a> did not provide information on the allocation concealment in the paper, but in the study protocol described that they used remote allocation and maintained allocation concealment up to the point of the intervention. <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> provided no information on sequence generation, but stated that they used "pre‐randomised sealed envelopes in blocks of 34". <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> did not specify the randomisation procedure, but according to the principal investigator this was adequately done at study sponsor level. Allocation concealment of individual participants does not apply to cluster‐RCTs at practice level, so we assessed <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>, in which most participants were cluster randomised, as at unclear risk of bias. </p> </section> <section id="CD010130-sec-0072"> <h4 class="title">Blinding</h4> <p>Measurement of C‐reactive protein and procalcitonin does not lend itself to blinding at the clinician level, as the intervention is used in management decisions, therefore lack of blinding for personnel administering the intervention was not a concern. Lack of blinding of participants and assessors may have been a concern for some outcomes, primarily participant‐reported outcomes. Our assessment of the number of participants given an antibiotic prescription was based on electronic or paper records for all studies. </p> <p>Secondary outcome data assessment procedure varied amongst studies. Seven studies used participant‐reported data on clinical recovery (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>). Two studies used blinded telephone interviews to assess secondary outcome data (<a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>). Five studies assessed secondary outcome data non‐blinded at follow‐up visits (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> did use participant‐reported clinical recovery, but remaining secondary outcome data were assessed non‐blinded by research staff at follow‐up visits. <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> did not present any secondary outcome data. </p> </section> <section id="CD010130-sec-0073"> <h4 class="title">Incomplete outcome data</h4> <p>We successfully retrieved incomplete outcome data on the number of participants given an antibiotic prescription by contacting the corresponding authors of individual studies when needed. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> provided missing data on our primary outcome number of participants given an antibiotic prescription (11% in the intervention group and 7% in the control group). </p> <p>Data on clinical recovery rates ranged from 90% to 98% in completeness for most studies, except for <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> and <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>. <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> had high rates of missing data for secondary outcomes (58.2%) due to missing consent forms from parents on included children. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> also reported a high rate of missing data for our secondary outcome number of satisfied participants (56.3%), but the reasons for this remain unclear.  </p> <p>We were unable to obtain information necessary for our planned subgroup analyses comparing serious and non‐serious infections, as this was not reported, and exact diagnoses were not recorded. However, we were able to obtain data on the effect of C‐reactive protein on the number of participants given an antibiotic prescription, which permitted a subgroup analysis of lower and upper ARIs. </p> </section> <section id="CD010130-sec-0074"> <h4 class="title">Selective reporting</h4> <p>Most studies were analysed as prespecified in study protocols accessed from trial registers. The two oldest studies did not have a published protocol (<a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> changed study set‐up. Although this was not specified in the protocol, we did not consider this change to have introduced reporting bias and it did not affect our risk of bias rating. We did not detect any selective reporting of particular outcome measurement or analysis. </p> </section> <section id="CD010130-sec-0075"> <h4 class="title">Other potential sources of bias</h4> <p>Selection (recruitment) bias is a risk in cluster‐RCTs, as care providers assigned to the intervention group can select which patients to test (inclusion was at the discretion of the care provider). This means that patients with a higher‐than‐average likelihood that the test might change the clinical decision could preferentially be enrolled, for example those patients that the care provider perceived could be convinced that an intervention was not needed if a test was performed. This may exaggerate the estimated effect relative to more widespread use in clinical practice. However, measures to limit this 'active' recruitment by participating physicians were in place, for example by requirements for consecutive enrolment of the first eligible patients that presented in each practice. In the study by <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>, significantly more participants in the control group had abnormalities on auscultation (60.3% versus 46.7%, P = 0.005), a parameter closely linked to antibiotic prescription (<a href="./references#CD010130-bbs2-0083" title="JakobsenKA , MelbyeH , KellyMJ , CeynowaC , MolstadS , HoodK , et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scandinavian Journal of Primary Health Care2010;28(4):229-36.">Jakobsen 2010</a>). However, in the larger study by <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>, symptom severity scores were balanced between groups. </p> <p>Contamination bias is possible in individual RCTs, as the general practitioner may gradually learn to foresee which patients have low C‐reactive protein levels and apply this acquired skill in the control group. As most patients will have low values of C‐reactive protein, this would lead to decreased antibiotic prescription in the control group and underestimate the effect of the test. </p> <p>Inclusion bias may occur in both trial designs, as general practitioners may be reluctant to include patients with severe disease given the risk that antibiotic treatment is not recommended according to the test result. In individual RCTs, this potential bias would be non‐discriminative, as opposed to in cluster‐RCTs, where this could be a discriminative bias. This may lead to a lower estimate of the effect of biomarkers in individual RCTs (a priori risk of antibiotic treatment is low in both groups) but may overestimate the effect in cluster‐RCTs (a priori risk of antibiotic treatment is different between intervention (low) and control groups (normal)). </p> </section> </section> <section id="CD010130-sec-0076"> <h3 class="title" id="CD010130-sec-0076">Effects of interventions</h3> <p>See: <a href="./full#CD010130-tbl-0001"><b>Summary of findings 1</b> Point‐of‐care biomarkers (C‐reactive protein) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</a>; <a href="./full#CD010130-tbl-0002"><b>Summary of findings 2</b> Point‐of‐care biomarkers (procalcitonin) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</a> </p> <section id="CD010130-sec-0077"> <h4 class="title">Defining follow‐up</h4> <p>We changed the wording used in the original review from “<i>at</i>  28 days follow‐up” and “<i>at</i>  day seven” to "<i>within</i> 28 days follow‐up” and "<i>within</i> seven days follow‐up” to specify the follow‐up period more precisely. This did not change our decision to include or exclude any specific studies from the review, but it did change which studies were included in our meta‐analysis.  </p> </section> <section id="CD010130-sec-0078"> <h4 class="title">Primary outcomes</h4> <section id="CD010130-sec-0079"> <h5 class="title">1. Number of participants given an antibiotic prescription at the index consultation and within 28 days follow‐up </h5> <section id="CD010130-sec-0080"> <h6 class="title">C‐reactive protein</h6> <p>See <a href="./full#CD010130-tbl-0001">summary of findings Table 1</a>. </p> <p>All 12 studies, including 10,218 participants (mean age 62), reported point estimates in favour of the C‐reactive protein test to reduce the number of participants given an antibiotic prescription. The pooled result for all included trials showed that C‐reactive protein tests likely reduce the number of participants given an antibiotic prescription (risk ratio (RR) 0.77, 95% confidence interval (CI) 0.69 to 0.86; 12 trials, 10,218 participants; I²<sup> </sup>= 79%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0007" title="">Analysis 1.1</a>; <a href="#CD010130-fig-0004">Figure 4</a>). However, the considerable heterogeneity was not explained through our pre‐planned subgroup analysis of cluster‐RCTs and individual RCTs. </p> <div class="figure" id="CD010130-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.1 C‐reactive protein ‐ antibiotics prescribed at index consultation. All trials (cluster‐RCTs with modified sample size)." data-id="CD010130-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.1 C‐reactive protein ‐ antibiotics prescribed at index consultation. All trials (cluster‐RCTs with modified sample size). </p> </div> </div> </div> <p>Pooled results from the individual RCTs showed that C‐reactive protein tests likely reduce the number of participants given an antibiotic prescription (RR 0.79, 95% CI 0.70 to 0.89; I² = 75%; 6 trials, 5899 participants; <a href="./references#CD010130-fig-0007" title="">Analysis 1.1</a>; moderate‐certainty evidence; <a href="#CD010130-fig-0004">Figure 4</a>), but again with considerable heterogeneity. A similar effect was seen with the cluster‐RCTs (RR 0.73, 95% CI 0.58 to 0.90; 6 trials, 4319 participants; I² = 82%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0007" title="">Analysis 1.1</a>; <a href="#CD010130-fig-0004">Figure 4</a>). </p> <p>The number needed to test (NNT) to avoid one patient being given an antibiotic prescription at the index consultation was 9 (95% CI 7 to 13; <a href="#CD010130-tbl-0010">Table 8</a>). </p> <div class="table" id="CD010130-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">C‐reactive protein ‐ number needed to test to save 1 antibiotic prescribing</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>NNT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>95% CI</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster‐RCT*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 to 20</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; NNT: number needed to test; RCT: randomised controlled trial </p> <p>*Cluster‐randomised trials with modified sample size.<br/>  </p> </div> </div> <p>Overall, C‐reactive protein tests reduced the number of participants given an antibiotic prescription within 28 days follow‐up (RR 0.81, 95% CI 0.76 to 0.86; 7 trials, 5091 participants; I² = 29%; high‐certainty evidence; <a href="./references#CD010130-fig-0008" title="">Analysis 1.2</a>; <a href="#CD010130-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD010130-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.2 C‐reactive protein ‐ antibiotics prescribed within 28 days (cluster‐RCTs with modified sample size)." data-id="CD010130-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.2 C‐reactive protein ‐ antibiotics prescribed within 28 days (cluster‐RCTs with modified sample size). </p> </div> </div> </div> </section> <section id="CD010130-sec-0081"> <h6 class="title">Procalcitonin</h6> <p>See <a href="./full#CD010130-tbl-0002">summary of findings Table 2</a>. </p> <p>One study including 317 participants (median age 53), reported point estimates in favour of the C‐reactive protein test to reduce the number of participants given an antibiotic prescription (RR 0.32, 95% CI 0.23 to 0.44; 1 trial, 317 participants; very low‐certainty evidence; <a href="./references#CD010130-fig-0028" title="">Analysis 2.1</a>). As only one study investigated procalcitonin, the evidence is very uncertain about the effect of procalcitonin on number of participants given an antibiotic prescription. </p> </section> </section> <section id="CD010130-sec-0082"> <h5 class="title">2. Number of participants with substantial improvement (including full recovery) within seven days follow‐up </h5> <section id="CD010130-sec-0083"> <h6 class="title">C‐reactive protein</h6> <p>C‐reactive protein tests likely do not reduce clinical recovery (defined as at least substantial improvement) within seven days follow‐up (RR 1.03, 95% CI 0.96 to 1.12; 4 trials, 3104 participants; I² = 0%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0009" title="">Analysis 1.3</a>). </p> </section> <section id="CD010130-sec-0084"> <h6 class="title">Procalcitonin</h6> <p>The evidence is very uncertain about the effect of procalcitonin tests on clinical recovery (RR 1.23 95% CI 0.93 to 1.62; 1 trial, 277 participants; very low‐certainty evidence; <a href="./references#CD010130-fig-0030" title="">Analysis 2.3</a>) </p> </section> </section> <section id="CD010130-sec-0085"> <h5 class="title">3. Total mortality within 28 days follow‐up</h5> <section id="CD010130-sec-0086"> <h6 class="title">C‐reactive protein</h6> <p>Nine out of the 12 included studies reported information on mortality (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). Three out of nine studies reported deaths during the follow‐up period (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>), and six trials reported no deaths (<a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). The three remaining studies did not report on mortality and were thus not included in the analysis (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). </p> <p>Pooled analysis showed that C‐reactive protein tests may not increase total mortality within 28 days follow‐up (RR 0.53, 95% CI 0.10 to 2.92; 9 trials, 7737 participants; I² = 0%; low‐certainty evidence; <a href="./references#CD010130-fig-0010" title="">Analysis 1.4</a>), but the number of events was small (2 in 4221 participants in the intervention group versus 3 in 3516 participants in the control group). </p> <p>Causes of death were pneumonia (1), respiratory failure (1), pneumothorax (1), or "unclear reasons" (2). All studies reported that deaths were unrelated to the intervention or procedure as determined by trial investigators. All participants who died received antibiotics at day 0, either at index consultation or upon admission to hospital. All deaths were amongst older adults with comorbidities. </p> </section> <section id="CD010130-sec-0087"> <h6 class="title">Procalcitonin</h6> <p>No deaths occurred during the trial that investigated procalcitonin.</p> </section> </section> </section> <section id="CD010130-sec-0088"> <h4 class="title">Secondary outcomes</h4> <section id="CD010130-sec-0089"> <h5 class="title">1. Number of participants in need of a reconsultation within 28 days follow‐up</h5> <section id="CD010130-sec-0090"> <h6 class="title">C‐reactive protein</h6> <p>Use of C‐reactive protein tests results in little or no difference in the number of participants in need of a reconsultation within 28 days follow‐up (RR 1.06, 95% CI 0.91 to 1.24; 7 trials, 6256 participants; I² = 0%; high‐certainty evidence; <a href="./references#CD010130-fig-0011" title="">Analysis 1.5</a>). </p> </section> <section id="CD010130-sec-0091"> <h6 class="title">Procalcitonin</h6> <p>The evidence is very uncertain about the effect of procalcitonin tests on the number of participants in need of a reconsultation within 28 days follow‐up (RR 1.00, 95% CI 0.69 to 1.46; 1 trial, 317 participants; very low‐certainty evidence; <a href="./references#CD010130-fig-0032" title="">Analysis 2.5</a>). </p> </section> </section> <section id="CD010130-sec-0092"> <h5 class="title">2. Number of participants in need of a hospital admission within 28 days follow‐up</h5> <section id="CD010130-sec-0093"> <h6 class="title">C‐reactive protein</h6> <p>Ten of the 12 included studies reported information on hospital admissions (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). Six of 10 studies reported hospital admissions during the follow‐up period (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>), and four studies reported no hospital admissions amongst the included participants (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>). The two remaining studies did not report information on hospital admission and were thus not included in the analysis (<a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). </p> <p>C‐reactive protein tests probably do not increase the number of participants in need of a hospital admission within 28 days follow‐up (RR 1.05, 95% CI 0.72 to 1.53; 10 trials, 7514 participants; I² = 0%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0012" title="">Analysis 1.6</a>).  </p> <p>Only two studies presented detailed information on the reasons for hospital admission (<a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>). Reasons for hospital admissions were listed as: cardiac (3), respiratory (16), generally unwell/fever (2), gastrointestinal symptoms (2), sinusitis (1), sepsis (1), other (i.e. hyponatraemia, fracture, anaemia) (4).  </p> <p>All hospitalisations were likely not related to the intervention. However, an increase in the risk of hospital admissions in the C‐reactive protein group cannot be ruled out, although the absolute event rate was low (57 in 4728 participants in the intervention group versus 48 in 3386 participants in the control group). Data were not available to determine the number of hospitalised participants who were withheld antibiotic treatment at the index consultation, nor their C‐reactive protein level at the index consultation. </p> </section> <section id="CD010130-sec-0094"> <h6 class="title">Procalcitonin</h6> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> reported on hospital admissions. There were four hospital admissions in the intervention group and two hospital admissions in the usual care group. Reasons for hospital admissions were: acute psychotic episode (1) and pneumonia (5). Data were not available to determine the number of hospitalised participants who were withheld antibiotic treatment at the index consultation, nor their procalcitonin level at the index consultation. </p> <p>The evidence is very uncertain about the effect of procalcitonin tests on the number of participants in need of a hospital admission within 28 days follow‐up (RR 1.40, 95% CI 0.26 to 7.51; 1 trial, 277 participants; very low‐certainty evidence; <a href="./references#CD010130-fig-0033" title="">Analysis 2.6</a>). </p> </section> </section> <section id="CD010130-sec-0095"> <h5 class="title">3. Duration of acute respiratory infection </h5> <section id="CD010130-sec-0096"> <h6 class="title">C‐reactive protein</h6> <p>Four studies reported the duration of the ARI as days with restrictions in daily activities due to the infection, but used different measures in their assessment, thereby precluding a pooled analysis (<a href="#CD010130-tbl-0004">Table 2</a>). <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a> reported no differences in the median symptom duration of the ARI to full recovery, whilst <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a> also provided this measure as a mean number of days. <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> reported the time to resolution of symptoms rated as moderately bad or worse. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> reported the time to resolution of symptoms. No differences were observed for any of these participant‐reported outcomes. </p> </section> <section id="CD010130-sec-0097"> <h6 class="title">Procalcitonin</h6> <p>The median duration of the ARI was 8 days in the procalcitonin group and 7 days in the usual care group at 28 days follow‐up (<a href="#CD010130-tbl-0005">Table 3</a>). </p> </section> </section> <section id="CD010130-sec-0098"> <h5 class="title">4. Number of satisfied participants</h5> <section id="CD010130-sec-0099"> <h6 class="title">C‐reactive protein</h6> <p>Three out of 12 studies reported information on patient satisfaction (<a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>). All three studies reported satisfaction in terms of satisfaction with care and consultation, either at index consultation, <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>, or after trial day 14 (<a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>). C‐reactive protein tests may not reduce the number of satisfied participants (RR 0.81, 95% CI 0.50 to 1.29; 3 trials, 1458 participants; I² = 40%; low‐certainty evidence). However, there was moderate heterogeneity (I² = 40%), possibly related to the use of different assessment scales, and the fact that only three studies reported patient satisfaction reduces the certainty of the effect estimate (<a href="./references#CD010130-fig-0013" title="">Analysis 1.7</a>).  </p> </section> <section id="CD010130-sec-0100"> <h6 class="title">Procalcitonin</h6> <p>The study on procalcitonin reported patient satisfaction regarding the consultation at consultation day (<a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>). Satisfaction was also reported with regard to the diagnosis found, treatment, and the amount of time spent with the primary care physician, using a standardised visit‐specific satisfaction instrument by a blinded phone interview at day 7.  </p> <p>The evidence is very uncertain about the effect of procalcitonin tests on the number of satisfied participants (RR 0.96, 95% CI 0.93 to 1.00; 1 trial, 308 participants; very low‐certainty evidence; <a href="./references#CD010130-fig-0034" title="">Analysis 2.7</a>). </p> </section> </section> <section id="CD010130-sec-0101"> <h5 class="title">5. Number of participants with substantial improvement (including full recovery) within 28 days follow‐up </h5> <section id="CD010130-sec-0102"> <h6 class="title">C‐reactive protein</h6> <p>Use of C‐reactive protein tests likely does not reduce the number of participants recovered (defined as at least substantial improvement) within 28 days follow‐up (RR 1.02, 95% CI 0.79 to 1.32; 5 trials, 2324 participants; I² = 0%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0014" title="">Analysis 1.8</a>). </p> </section> <section id="CD010130-sec-0103"> <h6 class="title">Procalcitonin</h6> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> did not report on recovery within 28 days follow‐up. </p> </section> </section> <section id="CD010130-sec-0104"> <h5 class="title">6. Subgroup analyses</h5> <section id="CD010130-sec-0105"> <h6 class="title">C‐reactive protein</h6> <section id="CD010130-sec-0106"> <p><b>Serious infections and less serious infections</b></p> <p>We had to omit our planned analysis of severe and less severe ARI due to lack of data. However, the effect of the C‐reactive protein test on the number of participants given an antibiotic prescription was similar for upper and lower ARIs (<a href="./references#CD010130-fig-0015" title="">Analysis 1.9</a>). Heterogeneity across subgroups was 0%, suggesting no variation in the mean effect in the subgroups. </p> </section> <section id="CD010130-sec-0107"> <p><b>Children and adults</b></p> <p>Four studies specifically reported on the effect of C‐reactive protein test in children (N = 2335), collectively finding that C‐reactive protein likely reduces the number of children given an antibiotic prescription (RR 0.78, 95% CI 0.67 to 0.91; 4 trials, 2335 participants; I² = 45%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0016" title="">Analysis 1.10</a>) (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). The effect was primarily seen in low‐ and middle‐income countries.  </p> <p>The test for subgroup differences (test for heterogeneity across subgroups) suggests there is no variability in the effect estimate between adults and children (I² = 0%) (<a href="./references#CD010130-fig-0016" title="">Analysis 1.10</a>). Points estimates and confidence intervals are also overlapping. </p> </section> <section id="CD010130-sec-0108"> <p><b>Type of point‐of‐care test</b></p> <p>We did not carry out a subgroup analysis on type of point‐of‐care test due to lack of studies on the use of procalcitonin and leukocyte point‐of‐care tests. </p> </section> <section id="CD010130-sec-0109"> <p><b>Trials with low risk of bias and high risk of bias</b></p> <p>As the intervention did not lend itself to blinding, we chose to omit this component when selecting studies for our subgroup analysis comparing trials at low risk of bias and at high risk of bias. Accordingly, <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a> was the only trial with an overall low risk of bias (<a href="#CD010130-fig-0003">Figure 3</a>). The primary outcome of the number of participants given an antibiotic prescription at index consultation was RR 0.77, 95% CI 0.60 to 0.98, which was similar to the trials at high risk of bias. </p> </section> <section id="CD010130-sec-0110"> <p><b>Cluster‐RCTs and individually randomised studies</b></p> <p>We carried out a subgroup analysis on cluster‐RCTs and individual RCTs in most analyses. The test for heterogeneity did not show any indication of a variation in the mean effect in the subgroups (I² = 0%). The test for subgroup differences suggests that there is no variation in the mean effect between the cluster RCTs and individual RCTs (I² = 0%). Points estimates and confidence intervals are also overlapping. </p> <p><b>Procalcitonin</b> </p> <p>As only one included study investigated the effect of procalcitonin, we did not carry out any subgroup analysis evaluating procalcitonin as point‐of‐care biomarker. </p> </section> </section> </section> <section id="CD010130-sec-0111"> <h5 class="title">7. Sensitivity analyses</h5> <section id="CD010130-sec-0112"> <h6 class="title">C‐reactive protein</h6> <section id="CD010130-sec-0113"> <p><b>Planned sensitivity analysis</b></p> <p>Due to considerable heterogeneity possibly related to variations in trial designs, we omitted the preplanned sensitivity analysis using a fixed‐effect meta‐analysis. </p> <p>Sensitivity analyses assuming a worst‐case scenario, where all participants in the C‐reactive protein group lost to follow‐up did not improve, and all participants in the control group lost to follow‐up did substantially improve, showed that C‐reactive protein tests may increase the number of participants given an antibiotic prescription (within 7 days follow‐up: RR 1.11, 95% CI 1.03 to 1.20; 4 trials, 3214 participants; I²= 0%; <a href="./references#CD010130-fig-0017" title="">Analysis 1.11</a>; within 28 days follow‐up: RR 1.37, 95% CI 1.01 to 1.85; 5 trials, 2506 participants; I²= 31%; <a href="./references#CD010130-fig-0018" title="">Analysis 1.12</a>). The sensitivity analysis raised some concerns regarding missing outcome data on recovery (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a>). <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a> had missing outcome data on recovery that were not equally distributed between the intervention group and the control group (22 participants with missing outcome data items in 162 participants in the intervention group versus 3 participants with missing outcome data items in 79 participants in the control group). <a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> had missing outcome data on recovery that were equally distributed between groups (22 missing outcome data items in 630 participants in group A, 17 missing outcome data items in 626 participants in group B, and 26 missing outcome data items in 649 participants in the control group). <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> had recovery data available in 230 of 239 participants within 7 days follow‐up and in 219 of 239 participants at 21 days follow‐up. <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a> had minor missing outcome data (176 out of 179 participants provided outcome data on recovery). </p> </section> <section id="CD010130-sec-0114"> <p><b>Post hoc sensitivity analysis</b></p> <p>We carried out a post hoc sensitivity analysis on follow‐up period, as we had to specify the follow‐up period that was not prespecified in the protocol or the original review. The post hoc sensitivity analysis on follow‐up period did not change which studies to include from the original review, but did change which studies to include from the current search carried out in June 2022 (<a href="./references#CD010130-fig-0019" title="">Analysis 1.13</a>; <a href="./references#CD010130-fig-0020" title="">Analysis 1.14</a>; <a href="./references#CD010130-fig-0021" title="">Analysis 1.15</a>; <a href="./references#CD010130-fig-0022" title="">Analysis 1.16</a>; <a href="./references#CD010130-fig-0023" title="">Analysis 1.17</a>; <a href="./references#CD010130-fig-0024" title="">Analysis 1.18</a>; <a href="./references#CD010130-fig-0025" title="">Analysis 1.19</a>; <a href="./references#CD010130-fig-0026" title="">Analysis 1.20</a>). </p> <p>To assess the considerable heterogeneity, we performed a post hoc sensitivity analysis of newer studies separately (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>), as these studies used specific guidance on antibiotic prescription if C‐reactive protein levels were &lt; 20 mg/L. This analysis showed that C‐reactive protein tests likely reduce the number of participants given an antibiotic prescription (RR 0.74, 95% CI 0.65 to 0.84; 9 trials, 8341 participants; I²= 82%; moderate‐certainty evidence; <a href="./references#CD010130-fig-0027" title="">Analysis 1.21</a>), but with considerable heterogeneity.  </p> <p>A summary of the secondary outcomes is presented in <a href="#CD010130-tbl-0011">Table 9</a> and <a href="#CD010130-tbl-0012">Table 10</a>. </p> <div class="table" id="CD010130-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">C‐reactive protein ‐ summary of secondary outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pooled results<sup>a</sup> </b> </p> <p><b>RR (95% CI); I²</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Individually randomised</b> </p> <p><b>RR (95% CI); I²</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cluster‐randomised</b> </p> <p><b>RR (95% CI); I²</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysis</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reconsultations day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06 (0.91 to 1.24); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.31 (0.90 to 1.89); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.01 (0.85 to 1.20); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.05 (0.72 to 1.53); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.69 to 1.51); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48 (0.36 to 6.17); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (0.50 to 1.29); 40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.15 (0.22 to 6.17); 62%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.55 to 1.51); 40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recovery day 28<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.79 to 1.32); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.8</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; RR: risk ratio</p> <p><sup>a</sup>When I² &gt; 40%, separate analyses of individually and cluster‐randomised trials are presented.<br/><sup>b</sup>Defined as at least substantial improvement. </p> </div> </div> <div class="table" id="CD010130-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Procalcitonin ‐ summary of secondary outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Analysis</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reconsultations day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (0.69 to 1.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.40 (0.26 to 7.51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (0.93 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.7</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; RR: risk ratio</p> </div> </div> </section> </section> <section id="CD010130-sec-0115"> <h6 class="title">Procalcitonin</h6> <p>As only one included study investigated the effect of procalcitonin, we did not carry out any sensitivity analysis evaluating procalcitonin as point‐of‐care biomarker. </p> </section> </section> <section id="CD010130-sec-0116"> <h5 class="title">7. Funnel plot</h5> <section id="CD010130-sec-0117"> <h6 class="title">C‐reactive protein</h6> <p>The funnel plot (<a href="#CD010130-fig-0006">Figure 6</a>) refers to the primary outcome of number of participants given an antibiotic prescription. It may be slightly asymmetrical, indicating a possible risk of publication bias which might be due to a lack of smaller, negative studies. Furthermore, the smaller included studies were cluster‐RCTs (<a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>), with lower methodological rigour (<a href="./references#CD010130-bbs2-0098" title="PageMJ , HigginsJP , ClaytonG , SterneJA , HróbjartssonA , SavovićJ . Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies. PLOS ONE2016;11(7):e0159267.">Page 2016</a>). </p> <div class="figure" id="CD010130-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of risk ratio (RR) from included trials with their standard error (SE) values on a logarithmic scale." data-id="CD010130-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of risk ratio (RR) from included trials with their standard error (SE) values on a logarithmic scale. </p> </div> </div> </div> </section> <section id="CD010130-sec-0118"> <h6 class="title">Procalcitonin</h6> <p>As only one included study investigated the effect of procalcitonin, we did not carry out a funnel plot for this study. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010130-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010130-sec-0119"></div> <section id="CD010130-sec-0120"> <h3 class="title" id="CD010130-sec-0120">Summary of main results</h3> <p>We identified seven new studies for this update (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>), for a total of 13 RCTs with 10,535 participants. Overall, the included studies were at unclear or low risk of bias. However, all studies were open‐labelled, thereby introducing high risk of bias due to lack of blinding. </p> <section id="CD010130-sec-0121"> <h4 class="title">C‐reactive protein</h4> <p>We found 12 studies that investigated the use of C‐reactive protein point‐of‐care test in ARIs in primary care, and concluded that C‐reactive protein point‐of‐care tests in ARIs in primary care likely reduce the number of participants given an antibiotic prescription, and do not increase the number of participants in need of a reconsultation within 28 days follow‐up. Tests are also unlikely to affect patient safety with regard to clinical recovery within 7 or 28 days follow‐up. Furthermore, C‐reactive protein tests may not increase mortality within 28 days follow‐up, and are unlikely to increase hospital admissions within 28 days follow‐up.  </p> <p>All included studies consistently showed a point estimate indicating a reduction in the number of participants given an antibiotic prescription. However, the precise effect estimate should be interpreted with caution due to the considerable heterogeneity, which may be partly explained by differences in inclusion criteria and design amongst the included studies, and application of C‐reactive protein algorithms for initiating or withholding antibiotics in some trials only. We carried out subgroup analyses on the number of participants given an antibiotic prescription at index consultation for adults and children, which showed C‐reactive protein point‐of‐care tests in both adults and children in primary care likely reduce antibiotic prescriptions at index consultation.  </p> <p>Overall, the number of participants given an antibiotic prescription at 28 days follow‐up was reduced at a similar rate when using C‐reactive protein measurements to guide antibiotic treatment of ARIs in primary care.  </p> </section> <section id="CD010130-sec-0122"> <h4 class="title">Procalcitonin</h4> <p>We found only one study that investigated the use of procalcitonin point‐of‐care test in ARIs in primary care, and the evidence is very uncertain about the effect of procalcitonin for all primary and secondary outcomes. </p> </section> </section> <section id="CD010130-sec-0123"> <h3 class="title" id="CD010130-sec-0123">Overall completeness and applicability of evidence</h3> <section id="CD010130-sec-0124"> <h4 class="title">C‐reactive protein</h4> <p>In general, the available evidence supports the use of C‐reactive protein as a point‐of‐care test in children and adults to guide antibiotic prescriptions for ARIs in primary care. The included trials were from Europe, Russia, and Asia, which are considerably different in terms of antibiotic use, application of C‐reactive protein algorithms, and organisation of primary care. The studies had high levels of completeness of reporting for the primary outcomes (100%); however, secondary outcomes varied in completeness of reporting from moderate (56%) to high (89%). All results were reported as intention‐to‐treat. </p> <section id="CD010130-sec-0125"> <h5 class="title">Biological variation</h5> <p>Our meta‐analysis included both children and adults. We carried out a subgroup analysis on adults (11 studies, sample size 7883) and children (4 studies, sample size 2335). The respective effect estimates for children and adults both showed a reduction, thus our results support application of C‐reactive protein point‐of‐care tests in both adults and children to guide antibiotic prescription for ARIs in primary care. </p> <p>The results of this review should not be generalised to include older adults above 80 years of age with severe comorbidities and/or immunocompromised patients, as this group of patients were excluded from the included studies or were underrepresented. It remains unclear how C‐reactive protein should be interpreted in people with severe comorbidities and immunodepression, and no specific algorithms are made for these groups.  </p> <p>Furthermore, this review encompassed different respiratory infections with varying anatomical localisation. We had to omit the pre‐planned subgroup analyses of serious infections and less serious infections, as most studies reported presence and type of symptoms rather than diagnoses or symptom severity. No new studies included in this update reported data for this comparison; however, C‐reactive protein point‐of‐care tests were found likely to reduce the number of participants given an antibiotic prescription for both upper and lower ARIs in older studies. </p> </section> </section> <section id="CD010130-sec-0126"> <h4 class="title">C‐reactive protein algorithms </h4> <p>The included studies used different algorithms for C‐reactive protein measurements based on different national guidelines or different available evidence. To some extent this can explain the observed heterogeneity. The C‐reactive protein algorithms affect both patient safety and the potential reduction in the number of patients given an antibiotic prescription, as does the a priori likelihood of antibiotic use in any given patient population. By including different algorithms in this review, we regard the findings as a 'proof of concept'; however, identification of an optimal algorithm was not possible.  </p> <p>In studies with specific algorithms (such as C‐reactive protein cut‐off &lt; 20 mg/L for withholding antibiotic treatment), physicians were still able to overrule the algorithm based on clinical assessment. Studies report that variation in adherence to the C‐reactive protein algorithms was present. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> reported variation in adherence to algorithm across the two included study centres (4% of participants (3/75) in the intervention group in Sai Dong station, and 71% of participants (49/71) in the intervention group in Dong Da Station), suggesting that adherence to protocol was study site‐specific. Mean violation of algorithm in the included studies was 28.6% (range 20% to 35%). This will also be present in practice, as a physician will have to interpret findings as an adjunct to medical history and clinical examination. </p> <section id="CD010130-sec-0127"> <h5 class="title">Variation in adherence</h5> <p>Two studies had issues regarding adherence to the protocol (<a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> reported violations to protocol, as one in five (18%) participants randomised to the control group where tested for C‐reactive protein. <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> reported a low (6%) usage of C‐reactive protein measurements in the intervention group. Both studies found a non‐significant reduction in the number of participants given an antibiotic prescription. <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> also demonstrates what may occur when introducing a point‐of‐care test in practice. Initial introduction including training in use and interpretation of C‐reactive protein tests produced a reduction (RR 0.69, 95% CI 0.61 to 0.77) in the number of participants given an antibiotic prescription (<a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>). However, subsequent follow‐up without further enforcement, training, or incentives to use the newly acquired skills may lead to discontinuation of the intervention and loss of its initial effect (<a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>). These interpretations, suggesting a continued support to clinicians upon introducing new interventions, may be relevant to consider if implementing C‐reactive protein testing on a wider scale (<a href="./references#CD010130-bbs2-0066" title="DamschroderLJ , AronDC , KeithRE , KirshSR , AlexanderJA , LoweryJC . Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Science2009;4:50. [DOI: 10.1186/1748-5908-4-50]">Damschroder 2009</a>).  </p> <p>Economic aspects on tests may also be a concern with regard to the implementation of C‐reactive protein tests. Point‐of‐care tests are easily accessible, but kits can be expensive, which may be a barrier for implementation of C‐reactive protein test for primary care in low‐ and middle‐income countries.  </p> </section> </section> <section id="CD010130-sec-0128"> <h4 class="title">Procalcitonin</h4> <section id="CD010130-sec-0129"> <h5 class="title">Biological variation</h5> <p>The study investigating the use of procalcitonin point‐of‐care test in ARI in primary care only included adults, therefore we have no evidence with regards to children. We are uncertain of the effect of procalcitonin on adults due to the level of the evidence.  </p> </section> <section id="CD010130-sec-0130"> <h5 class="title">Algorithms </h5> <p>The algorithm used in the study was to prescribe antibiotics when procalcitonin was &gt; 0.25 μg/L. This cut‐off point was made based on previous RCTs (<a href="./references#CD010130-bbs2-0052" title="BrielM , SchuetzP , MuellerB , YoungJ , SchildU , NusbaumerC , et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Archives of Internal Medicine2008;168(18):2000-7. [DOI: 10.1001/archinte.168.18.2000.]">Briel 2008b</a>; <a href="./references#CD010130-bbs2-0054" title="BurkhardtO , EwigS , HaagenU , GiersdorfS , HartmannO , WegscheiderK , et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. European Respiratory Journal2010;36(3):601-7. [DOI: 10.1183/09031936.00163309]">Burkhardt 2010b</a>; <a href="./references#CD010130-bbs2-0104" title="SchuetzP , Christ-CrainM , ThomannR , FalconnierC , WolbersM , WidmerI , et al, ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA2009;302(10):1059-66. [DOI: 10.1001/jama.2009.1297]">Schuetz 2009</a>). The study carried out a per‐protocol characteristics of participants having received antibiotics between day 1 and 28 despite procalcitonin &lt; 0.25 μg/L at day 0. Only presence of chest pain and longer duration of symptoms were associated with antibiotic prescription despite procalcitonin &lt; 0.25 μg/L at day 0.  </p> </section> <section id="CD010130-sec-0131"> <h5 class="title">Variation in adherence</h5> <p>There was no protocol violation with regard to adherence to protocol in the usual care group in the study. There were deviations in 8% in the procalcitonin group, meaning that 8% did not have procalcitonin measured. </p> <p>Economic aspects on procalcitonin may also be a concern with regard to the implementation of procalcitonin point‐of‐care tests for primary care in low‐ and middle‐income countries.  </p> <p>Procalcitonin as point‐of‐care test provides results in 20 minutes. This may also be a concern with regard to implementation of the test in primary care. </p> </section> </section> </section> <section id="CD010130-sec-0132"> <h3 class="title" id="CD010130-sec-0132">Certainty of the evidence</h3> <section id="CD010130-sec-0133"> <h4 class="title">C‐reactive protein</h4> <p>The overall certainty of the evidence was moderate to high according to our GRADE assessment, except for mortality, which we downgraded by two levels due to substantial imprecision (<a href="./full#CD010130-tbl-0001">summary of findings Table 1</a>). Further research is unlikely to alter our overall conclusions, but may change the effect estimates due to the current heterogeneity. </p> <p>Considerable heterogeneity in the pooled analysis of the number of participants given an antibiotic prescription at the index consultation may well be explained by differences in study setting (geographical locations and different primary care settings), as well as the application of different C‐reactive protein algorithms (<a href="#CD010130-tbl-0008">Table 6</a>). However, we downgraded the certainty of the evidence due to the considerable, unexplained heterogeneity. </p> <p>We downgraded the certainty of the evidence for the outcomes total mortality and hospital admissions within 28 days follow‐up due to imprecision. We chose to downgrade hospital admissions by one level, but downgraded mortality by two levels as there were few events and wide confidence intervals, where the upper limit of the confidence interval could in theory include clinically meaningful differences. The low event rates for these safety outcomes prevented us from drawing any firm conclusions, although it seems unlikely that the intervention substantially increases mortality or hospital admission based on the available data. </p> <p>Clinical recovery rates were participant‐reported outcomes, and we chose to downgrade the certainty of the evidence to moderate due to lack of blinding of participants. The rating of high risk of bias will likely not be changed by future research, as blinding is impossible due to the nature of the intervention. We chose not to downgrade for missing data on recovery, despite the fact that our worst‐case sensitivity analysis showed differences in favour of standard care. The worst‐case analysis might not be the best way to handle missing data (<a href="./references#CD010130-bbs2-0075" title="HigginsJP , WhiteIR , WoodAM . Imputation methods for missing outcome data in meta-analysis of clinical trials. Clinical Trials2008;5(3):225-39. [DOI: 10.1177/1740774508091600]">Higgins 2008</a>), but this specific analysis does remind us to be aware of missing data, which could potentially change the overall effect estimate on recovery. </p> </section> <section id="CD010130-sec-0134"> <h4 class="title">Procalcitonin</h4> <p>As already mentioned, the evidence is very uncertain about the effect of procalcitonin on all primary and secondary outcomes. More studies are needed to evaluate the use of procalcitonin point‐of‐care tests in ARIs in primary care. </p> <p>We downgraded the certainty of the evidence for the use of procalcitonin in general because we identified only one study, with a small study sample. We chose to downgrade two levels due to imprecision. Another reason for downgrading the certainty of the evidence for the use of procalcitonin in ARI in primary care was indirectness, as only adults were included. This could be discussed, but we are interested in the effect of the use of procalcitonin in the population in primary care, not only in adults. </p> <p>We chose to downgrade the certainty of the evidence by one level due to study limitations, because the study was a cluster‐randomised trial. Only one study was included, and we are uncertain whether individually randomised trials will provide the same effect estimate as this cluster‐randomised trial. </p> <p>We were unable to assess the certainty of the evidence with regard to inconsistency of results, as only one study was included. </p> </section> </section> <section id="CD010130-sec-0135"> <h3 class="title" id="CD010130-sec-0135">Potential biases in the review process</h3> <p>To the best of our knowledge, no bias was introduced in the review process.</p> </section> <section id="CD010130-sec-0136"> <h3 class="title" id="CD010130-sec-0136">Agreements and disagreements with other studies or reviews</h3> <p>Three systematic reviews studied the evidence for C‐reactive protein point‐of‐care tests to guide antibiotic prescription in primary care (<a href="./references#CD010130-bbs2-0067" title="EngelMF , PalingFP , HoepelmanAI , van derMeerV , OosterheertJJ . Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Family Practice2011;29:383-93.">Engel 2011</a>; <a href="./references#CD010130-bbs2-0081" title="HuangY , ChenR , WuT , WeiX , GuoA . Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. British Journal of General Practice2013;63(616):e787-94.">Huang 2013</a>; <a href="./references#CD010130-bbs2-0090" title="Martínez-GonzálezN , KeizerA , PlateE , CoenenA , ValeriS , VerbakelF , et al. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials. Antibiotics (Basel, Switzerland) 2020;9(9):610. [DOI: 10.3390/antibiotics9090610]">Martínez‐González 2020</a>). <a href="./references#CD010130-bbs2-0067" title="EngelMF , PalingFP , HoepelmanAI , van derMeerV , OosterheertJJ . Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Family Practice2011;29:383-93.">Engel 2011</a> concluded that the current evidence does not support the use of C‐reactive protein in primary care for this purpose. However, no meta‐analyses were performed, with no reason for this provided. <a href="./references#CD010130-bbs2-0081" title="HuangY , ChenR , WuT , WeiX , GuoA . Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. British Journal of General Practice2013;63(616):e787-94.">Huang 2013</a>, like us, reported a reduction in the number of participants given an antibiotic prescription for ARIs (RR 0.75, 95% CI 0.67 to 0.83), but with considerable heterogeneity (I² = 76%). However, the main meta‐analysis included both RCTs and observational studies. Both <a href="./references#CD010130-bbs2-0067" title="EngelMF , PalingFP , HoepelmanAI , van derMeerV , OosterheertJJ . Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Family Practice2011;29:383-93.">Engel 2011</a> and <a href="./references#CD010130-bbs2-0081" title="HuangY , ChenR , WuT , WeiX , GuoA . Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. British Journal of General Practice2013;63(616):e787-94.">Huang 2013</a> did not include the eight latest trials, which added 8785 participants (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>; <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a>). </p> <p>A more recent systematic review reported a reduction in the number of participants given an antibiotic prescription in ARI (RR 0.79, 95% CI 0.79 to 0.90), also with considerable heterogeneity (I² = 76%) (<a href="./references#CD010130-bbs2-0090" title="Martínez-GonzálezN , KeizerA , PlateE , CoenenA , ValeriS , VerbakelF , et al. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials. Antibiotics (Basel, Switzerland) 2020;9(9):610. [DOI: 10.3390/antibiotics9090610]">Martínez‐González 2020</a>). The review included five studies that we chose to exclude (<a href="./references#CD010130-bbs2-0021" title="GonzalesR , AagaardEM , Camargo CA Jr, MaOJ , PlautzM , MaselliJH , et al. C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. Journal of Emergency Medicine2011;41(1):1-7. ">Gonzales 2011</a>; <a href="./references#CD010130-bbs2-0101" title="RebnordIK , SandvikH , MjelleAB , HunskaarS . Out-of-hours antibiotic prescription after screening with C reactive protein: a randomised controlled study. BMJ Open2016;12(6):e011231. [DOI: 10.1136/bmjopen-2016-011231]">Rebnord 2016b</a>; <a href="./references#CD010130-bbs2-0036" title="TakemuraY , EbisawaK , KakoiH , SaitohH , KureH , IshidaH , et al. Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count. Journal of Clinical Pathology2005;58(7):729-33. ">Takemura 2005</a>; <a href="./references#CD010130-bbs2-0037" title="Van den BruelA , JonesC , ThompsonM , MantD . C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Archive of Diseases in Childhood2016;101(4):382-5. [DOI: 10.1136/archdischild-2015-309228]">Van den Bruel 2016</a>; <a href="./references#CD010130-bbs2-0038" title="LemiengreMB , VerbakelJY , ColmanR , De BurghgraeveT , BuntinxF , AertgeertsB , et al. Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions. British Journal of General Practice2018;68(668):e204-10. LemiengreMB , VerbakelJY , ColmanR , Van RoyK , De BurghgraeveT , BuntinxF , et al. Point-of-care CRP matters: normal CRP levels reduce immediate antibiotic prescribing for acutely ill children in primary care: a cluster randomized controlled trial. Scandinavian Journal of Primary Health Care 2018;36(4):423-36. [DOI: 10.1080/02813432.2018.1529900]VerbakelJY , LemiengreMB , De BurghgraeveT , De SutterA , AertgeertsB , ShinkinsB , et al. Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial. BMC Medicine2016;14(1):131. [DOI: 10.1186/s12916-016-0679-2.]">Verbakel 2016</a>). <a href="./references#CD010130-bbs2-0021" title="GonzalesR , AagaardEM , Camargo CA Jr, MaOJ , PlautzM , MaselliJH , et al. C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. Journal of Emergency Medicine2011;41(1):1-7. ">Gonzales 2011</a> was conducted in an emergency department, whereas our review focused on primary care. Three trials included participants with acute illness (fever) that were not specifically ARIs, which were the conditions of interest in our review (<a href="./references#CD010130-bbs2-0101" title="RebnordIK , SandvikH , MjelleAB , HunskaarS . Out-of-hours antibiotic prescription after screening with C reactive protein: a randomised controlled study. BMJ Open2016;12(6):e011231. [DOI: 10.1136/bmjopen-2016-011231]">Rebnord 2016b</a>; <a href="./references#CD010130-bbs2-0036" title="TakemuraY , EbisawaK , KakoiH , SaitohH , KureH , IshidaH , et al. Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count. Journal of Clinical Pathology2005;58(7):729-33. ">Takemura 2005</a>; <a href="./references#CD010130-bbs2-0037" title="Van den BruelA , JonesC , ThompsonM , MantD . C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Archive of Diseases in Childhood2016;101(4):382-5. [DOI: 10.1136/archdischild-2015-309228]">Van den Bruel 2016</a>). We excluded <a href="./references#CD010130-bbs2-0038" title="LemiengreMB , VerbakelJY , ColmanR , De BurghgraeveT , BuntinxF , AertgeertsB , et al. Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions. British Journal of General Practice2018;68(668):e204-10. LemiengreMB , VerbakelJY , ColmanR , Van RoyK , De BurghgraeveT , BuntinxF , et al. Point-of-care CRP matters: normal CRP levels reduce immediate antibiotic prescribing for acutely ill children in primary care: a cluster randomized controlled trial. Scandinavian Journal of Primary Health Care 2018;36(4):423-36. [DOI: 10.1080/02813432.2018.1529900]VerbakelJY , LemiengreMB , De BurghgraeveT , De SutterA , AertgeertsB , ShinkinsB , et al. Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial. BMC Medicine2016;14(1):131. [DOI: 10.1186/s12916-016-0679-2.]">Verbakel 2016</a> as this study had no usual care group and carried out a more complex intervention. <a href="./references#CD010130-bbs2-0090" title="Martínez-GonzálezN , KeizerA , PlateE , CoenenA , ValeriS , VerbakelF , et al. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials. Antibiotics (Basel, Switzerland) 2020;9(9):610. [DOI: 10.3390/antibiotics9090610]">Martínez‐González 2020</a> also conducted a subgroup analysis comparing age groups, but only found a likely reduction in the number of participants given an antibiotic prescription amongst adults (n = 3729), not children (n = 2755). <a href="./references#CD010130-bbs2-0090" title="Martínez-GonzálezN , KeizerA , PlateE , CoenenA , ValeriS , VerbakelF , et al. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials. Antibiotics (Basel, Switzerland) 2020;9(9):610. [DOI: 10.3390/antibiotics9090610]">Martínez‐González 2020</a> detected greater heterogeneity in the subgroup analysis of children (I² = 67% versus I² = 45% in our subgroup analysis), and some included children (n = 1684) had acute illness rather than ARIs (<a href="./references#CD010130-bbs2-0037" title="Van den BruelA , JonesC , ThompsonM , MantD . C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Archive of Diseases in Childhood2016;101(4):382-5. [DOI: 10.1136/archdischild-2015-309228]">Van den Bruel 2016</a>; <a href="./references#CD010130-bbs2-0038" title="LemiengreMB , VerbakelJY , ColmanR , De BurghgraeveT , BuntinxF , AertgeertsB , et al. Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions. British Journal of General Practice2018;68(668):e204-10. LemiengreMB , VerbakelJY , ColmanR , Van RoyK , De BurghgraeveT , BuntinxF , et al. Point-of-care CRP matters: normal CRP levels reduce immediate antibiotic prescribing for acutely ill children in primary care: a cluster randomized controlled trial. Scandinavian Journal of Primary Health Care 2018;36(4):423-36. [DOI: 10.1080/02813432.2018.1529900]VerbakelJY , LemiengreMB , De BurghgraeveT , De SutterA , AertgeertsB , ShinkinsB , et al. Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial. BMC Medicine2016;14(1):131. [DOI: 10.1186/s12916-016-0679-2.]">Verbakel 2016</a>). Another concern was the study by <a href="./references#CD010130-bbs2-0101" title="RebnordIK , SandvikH , MjelleAB , HunskaarS . Out-of-hours antibiotic prescription after screening with C reactive protein: a randomised controlled study. BMJ Open2016;12(6):e011231. [DOI: 10.1136/bmjopen-2016-011231]">Rebnord 2016b</a>, which combined two settings, an out‐of‐hours primary care clinic and a paediatric emergency department. </p> <p>Two systematic reviews studied the evidence of point‐of‐care tests in ambulatory care (<a href="./references#CD010130-bbs2-0116" title="Van HeckeO , RaymondM , LeeJJ , TurnerP , GoyderCR , VerbakelJY , et al. In-vitro diagnostic point-of-care tests in paediatric ambulatory care: a systematic review and meta-analysis. PLOS ONE2020;15(7):0235605. [DOI: 10.1371/journal.pone.0235605]">Van Hecke 2020</a>; <a href="./references#CD010130-bbs2-0118" title="VerbakelJY , LeeJJ , GoyderC , TanPS , AnanthakumarT , TurnerPJ , et al. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open2019;9(1):e025036. [DOI: 10.1136/bmjopen-2018-025036]">Verbakel 2019</a>). Both reviews included studies conducted not only in primary care but also emergency departments, ambulatory care, and outpatient clinics. The evidence for both reviews was in concordance to ours. <a href="./references#CD010130-bbs2-0118" title="VerbakelJY , LeeJJ , GoyderC , TanPS , AnanthakumarT , TurnerPJ , et al. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open2019;9(1):e025036. [DOI: 10.1136/bmjopen-2018-025036]">Verbakel 2019</a> reported a likely reduction of the number of participants given an antibiotic prescription (RR 0.81, 95% CI 0.71 to 0.92). When including guidance on antibiotic prescriptions in accordance to C‐reactive protein level, a further reduction was found (RR 0.68, 95% CI 0.63 to 0.74 in adults and RR 0.56, 95% CI 0.33 to 0.95 in children), also with substantial heterogeneity (I² = 72%). <a href="./references#CD010130-bbs2-0116" title="Van HeckeO , RaymondM , LeeJJ , TurnerP , GoyderCR , VerbakelJY , et al. In-vitro diagnostic point-of-care tests in paediatric ambulatory care: a systematic review and meta-analysis. PLOS ONE2020;15(7):0235605. [DOI: 10.1371/journal.pone.0235605]">Van Hecke 2020</a> concluded that point‐of‐care C‐reactive protein tests may reduce immediate antibiotic prescribing amongst children by a third (risk difference ‐0.29, 95% CI ‐0.47 to ‐0.11; n = 2747) in ARI in low‐ and middle‐income (LMIC) countries. This difference was seen in RCTs in LMICs that included guidance on interpretation of point‐of‐care C‐reactive protein tests, specific training, or employed a diagnostic algorithm prior to point‐of‐care testing. Our subgroup analysis of children also found a more pronounced effect in LMIC countries (<a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a>; <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a>). Together, these findings suggest that the impact of point‐of‐care C‐reactive protein tests is context‐specific. Settings with high baseline antibiotic prescription rates might benefit more from an implementation of point‐of‐care C‐reactive protein test than settings with low baseline antibiotic prescription rates. These observations likely contribute to the substantial heterogeneity detected.  </p> <p>According to <a href="./references#CD010130-bbs2-0118" title="VerbakelJY , LeeJJ , GoyderC , TanPS , AnanthakumarT , TurnerPJ , et al. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open2019;9(1):e025036. [DOI: 10.1136/bmjopen-2018-025036]">Verbakel 2019</a> mortality was generally underreported, and this review called for safety assessments for implementing point‐of‐care C‐reactive protein test in ambulatory care. To our knowledge, no reviews and only a few randomised studies have assessed the use of point‐of care C‐reactive protein tests in primary care amongst older adults with frailty and severe comorbidities (<a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>). This is a concern as frail older adults with comorbidity contributes with a high amount of consultations due to acute respiratory infection in primary care (<a href="./references#CD010130-bbs2-0062" title="ChildsA , ZulloAR , JoyceNR , McConeghyKW , vanAalstR , MoyoP , et al. The burden of respiratory infections among older adults in long-term care: a systematic review. BMC Geriatrics2019;19(1):210. [DOI: 10.1186/s12877-019-1236-6]">Childs 2019</a>; <a href="./references#CD010130-bbs2-0063" title="CillónizC , Rodríguez-HurtadoD , TorresA . Characteristics and management of community-acquired pneumonia in the era of global aging. Medical Sciences (Basel, Switzerland)2018;6(2):35. [DOI: 10.3390/medsci6020035]">Cillóniz 2018</a>; <a href="./references#CD010130-bbs2-0112" title="StupkaJE , MortensenEM , AnzuetoA , RestrepoMI . Community-acquired pneumonia in elderly patients. Aging Health2009;5(6):763-74. [DOI: 10.2217/ahe.09.74]">Stupka 2009</a>). More studies are needed to assess the safety of using C‐reactive protein tests to guide antibiotic prescriptions in frail, multimorbid older adults in primary care.  </p> <p>One study systematically screened the evidence for interventions that reduce antibiotic prescriptions in primary care amongst people suffering from ARIs (<a href="./references#CD010130-bbs2-0084" title="Köchling A, Löffler C, Reinsch S, Hornung A, Böhmer F, Altiner A, et al. Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review. Implementation Science2018;13(1):47. [DOI: 10.1186/s13012-018-0732-y]">Köchling 2018</a>). The review included 17 studies, and concluded that communication skills training and point‐of‐care tests were the most effective interventions, in combination or alone. Observed reductions in antibiotic use ranged from 1.5% to 23.3% depending on intervention type (<a href="./references#CD010130-bbs2-0084" title="Köchling A, Löffler C, Reinsch S, Hornung A, Böhmer F, Altiner A, et al. Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review. Implementation Science2018;13(1):47. [DOI: 10.1186/s13012-018-0732-y]">Köchling 2018</a>). These findings are similar to ours, and some studies included in our meta‐analysis also compared communication training to C‐reactive protein point‐of‐care testing and showed similar potential to reduce antibiotic use, whilst an additive effect was observed when both C‐reactive protein tests and training sessions in communication skills were combined (<a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a>). </p> <p>During the last decade, several cost‐effectiveness studies on C‐reactive protein have been conducted in European settings (<a href="./references#CD010130-bbs2-0059" title="CalsJW , AmentAJ , HoodK , ButlerCC , HopstakenRM , WassinkGF , et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. Journal of Evaluation in Clinical Practice2011;17(6):1059-69. [DOI: 10.1111/j.1365-2753.2010.01472.x.]">Cals 2011</a>; <a href="./references#CD010130-bbs2-0069" title="FawsittCG , LuceyD , HarringtonP , JordanK , MarshallL , O'BrienKK , et al. A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model. Family Practice2022;39:389-97. [DOI: 10.1093/fampra/cmab123.]">Fawsitt 2021</a>; <a href="./references#CD010130-bbs2-0082" title="HunterR . Cost-effectiveness of point-of-care C-reactive protein tests for respiratory tract infection in primary care in England. Advances in Therapy2015;32(1):69-85. [DOI: 10.1007/s12325-015-0180-x.]">Hunter 2015</a>; <a href="./references#CD010130-bbs2-0087" title="LingervelderD , KoffijbergH , KustersRI , JzermanMJ . Health economic evidence of point-of-care testing: a systematic review. PharmacoEconomics - Open2021;5(2):157-73. [DOI: 10.1007/s41669-020-00248-1]">Lingervelder 2021</a>; <a href="./references#CD010130-bbs2-0097" title="OppongR , JitM , SmithRD , ButlerCC , MelbyeH , MölstadS , et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. British Journal of General Practice2013;63(612):e465-71. [DOI: 10.3399/bjgp13X669185.]">Oppong 2013</a>). A majority of the studies concluded that C‐reactive protein testing increases healthcare costs. When calculating quality‐adjusted life‐years (QALYs), C‐reactive protein is cost‐effective alone or in combination with communication skills training, and is likely to provide a cost‐effective diagnostic intervention in terms of reducing prescription of antibiotics as well as in QALYs gained. To our knowledge, no cost‐effectiveness studies have included cost savings from potential reduction of antibiotic resistance, as no generally accepted threshold of a particular quantum of antibiotic prescribing has been accepted as cost‐effective. </p> <p>C‐reactive protein guidance in primary care has primarily been implemented in high‐income countries (<a href="./references#CD010130-bbs2-0095" title="National Institute for Health and Care Excellence (NICE). Pneumonia in adults: diagnosis and management. www.ncbi.nlm.nih.gov/books/NBK552669/ (accessed prior to 27 September 2022).">NICE Clinical Guidelines 2019</a>; <a href="./references#CD010130-bbs2-0124" title="WoodheadM , BlasiF , EwigS , GarauJ , HuchonG , IevenM , et al. Guidelines for the management of adult lower respiratory tract infections - full version. Clinical Microbiology and Infection2011;17(Suppl 6):E1-59.">Woodhead 2011</a>), even though evidence suggests that settings with high baseline antibiotic prescription rates might benefit more from an implementation of point‐of‐care C‐reactive protein test (<a href="./references#CD010130-bbs2-0116" title="Van HeckeO , RaymondM , LeeJJ , TurnerP , GoyderCR , VerbakelJY , et al. In-vitro diagnostic point-of-care tests in paediatric ambulatory care: a systematic review and meta-analysis. PLOS ONE2020;15(7):0235605. [DOI: 10.1371/journal.pone.0235605]">Van Hecke 2020</a>). Furthermore, no specific C‐reactive protein cut‐off threshold exists. European guidelines follow recommendations to delay prescription of antibiotics when C‐reactive protein levels are &lt; 20 mg/L and prescribe when &gt; 100 mg/L (<a href="./references#CD010130-bbs2-0095" title="National Institute for Health and Care Excellence (NICE). Pneumonia in adults: diagnosis and management. www.ncbi.nlm.nih.gov/books/NBK552669/ (accessed prior to 27 September 2022).">NICE Clinical Guidelines 2019</a>; <a href="./references#CD010130-bbs2-0124" title="WoodheadM , BlasiF , EwigS , GarauJ , HuchonG , IevenM , et al. Guidelines for the management of adult lower respiratory tract infections - full version. Clinical Microbiology and Infection2011;17(Suppl 6):E1-59.">Woodhead 2011</a>), although several studies suggest that different thresholds are needed depending on age (<a href="./references#CD010130-bbs2-0096" title="NouvenneA , TicinesiA , FolesaniG , CerundoloN , PratiB , MorelliI , et al. The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study. BMC Geriatrics2016;15(16):16. [DOI: 10.1186/s12877-016-0192-7.]">Nouvenne 2016</a>; <a href="./references#CD010130-bbs2-0114" title="Van den BruelA , ThompsonMJ , Haj-HassanT , StevensR , MollH , LakhanpaulM , et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ2011;342:d3082. [DOI: 10.1136/bmj.d3082.]">Van den Bruel 2011</a>; <a href="./references#CD010130-bbs2-0116" title="Van HeckeO , RaymondM , LeeJJ , TurnerP , GoyderCR , VerbakelJY , et al. In-vitro diagnostic point-of-care tests in paediatric ambulatory care: a systematic review and meta-analysis. PLOS ONE2020;15(7):0235605. [DOI: 10.1371/journal.pone.0235605]">Van Hecke 2020</a>; <a href="./references#CD010130-bbs2-0118" title="VerbakelJY , LeeJJ , GoyderC , TanPS , AnanthakumarT , TurnerPJ , et al. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open2019;9(1):e025036. [DOI: 10.1136/bmjopen-2018-025036]">Verbakel 2019</a>). Studies have reported that the C‐reactive protein test may not be sufficiently sensitive and specific to be of diagnostic value in primary care, where the incidence of serious bacterial infection is low (<a href="./references#CD010130-bbs2-0068" title="FalkG , FaheyT . C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Family Practice2009;26(1):10-21.">Falk 2009</a>; <a href="./references#CD010130-bbs2-0115" title="van derMeerV , NevenAK , vanden BroekPJ , AssendelftWJ . Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ2005;331(7507):26.">van der Meer 2005</a>). Still, it may be used as a prognostic marker to determine the likelihood of a non‐serious infection. Low C‐reactive protein levels may assist in ruling out serious bacterial infections and withhold unnecessary antibiotic treatments that are not likely to benefit the patient. Of note, C‐reactive protein is not a perfect test and should only be used in the relevant clinical context, as risks exist for over‐ as well as undertreatment with antibiotics.  </p> <p>C‐reactive protein is the only point‐of‐care test widely used in primary care. However, procalcitonin, another biomarker of infection, has been developed as a point‐of‐care‐test. We only found one study carried out in primary care that investigated the use of procalcitonin point‐of‐care test to guide decisions about antibiotic treatment of ARIs. Primarily due to few participants, the certainty of evidence for procalcitonin as a test to guide antibiotic treatment is too low to permit any definitive conclusions. A Cochrane Review from 2017 suggests that procalcitonin is a safe and effective tool to guide decisions about antibiotic treatment of ARIs (<a href="./references#CD010130-bbs2-0105" title="SchuetzP , MullerB , Christ-CrainM , StolzD , TammM , BouadmaL , et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD007498. [DOI: 10.1002/14651858.CD007498.pub3]">Schuetz 2017</a>), but only one out of the 17 studies included in <a href="./references#CD010130-bbs2-0105" title="SchuetzP , MullerB , Christ-CrainM , StolzD , TammM , BouadmaL , et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD007498. [DOI: 10.1002/14651858.CD007498.pub3]">Schuetz 2017</a> used procalcitonin as a point‐of‐care test, and the study was conducted in an emergency department. Safety aspects could not be assessed in primary care due to low mortality rates.  </p> <p>To our knowledge, no new biomarkers as point‐of‐care test have been evaluated in an RCT in primary care.  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010130-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010130-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010130-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010130-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.1 C‐reactive protein ‐ antibiotics prescribed at index consultation. All trials (cluster‐RCTs with modified sample size)." data-id="CD010130-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.1 C‐reactive protein ‐ antibiotics prescribed at index consultation. All trials (cluster‐RCTs with modified sample size). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.2 C‐reactive protein ‐ antibiotics prescribed within 28 days (cluster‐RCTs with modified sample size)." data-id="CD010130-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 C‐reactive protein ‐ antibiotic prescribing: all trials, outcome: 1.2 C‐reactive protein ‐ antibiotics prescribed within 28 days (cluster‐RCTs with modified sample size). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of risk ratio (RR) from included trials with their standard error (SE) values on a logarithmic scale." data-id="CD010130-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of risk ratio (RR) from included trials with their standard error (SE) values on a logarithmic scale. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 1: CRP ‐ Antibiotics prescribed at index consultation. All trials (cluster‐randomised with modified sample size)" data-id="CD010130-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 1: CRP ‐ Antibiotics prescribed at index consultation. All trials (cluster‐randomised with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 2: CRP ‐ Antibiotics prescribed within 28 days follow‐up (cluster‐randomised trials with modified sample size)" data-id="CD010130-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 2: CRP ‐ Antibiotics prescribed within 28 days follow‐up (cluster‐randomised trials with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 3: CRP ‐ Number of participants substantially improved within 7 days follow‐up" data-id="CD010130-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 3: CRP ‐ Number of participants substantially improved within 7 days follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 4: CRP ‐ Mortality (cluster‐randomised trials with modified sample size)" data-id="CD010130-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 4: CRP ‐ Mortality (cluster‐randomised trials with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 5: CRP ‐ Number of reconsultations within 28 days follow‐up" data-id="CD010130-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 5: CRP ‐ Number of reconsultations within 28 days follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 6: CRP ‐ Hospital admissions (cluster‐randomised with modified sample size)" data-id="CD010130-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 6: CRP ‐ Hospital admissions (cluster‐randomised with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 7: CRP ‐ Patient satisfaction" data-id="CD010130-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 7: CRP ‐ Patient satisfaction</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 8: CRP ‐ Number of participants substantially improved within 28 days follow‐up (cluster‐randomised trials with modified sample size)" data-id="CD010130-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 8: CRP ‐ Number of participants substantially improved within 28 days follow‐up (cluster‐randomised trials with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 9: CRP ‐ Subgroup analysis: antibiotics prescribed at index consultation: upper respiratory tract infections and lower respiratory tract infections (cluster‐randomised trials with modified sample size)" data-id="CD010130-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 9: CRP ‐ Subgroup analysis: antibiotics prescribed at index consultation: upper respiratory tract infections and lower respiratory tract infections (cluster‐randomised trials with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 10: CRP ‐ Subgroup analysis: children and adults. Antibiotic prescribing at index consultation" data-id="CD010130-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 10: CRP ‐ Subgroup analysis: children and adults. Antibiotic prescribing at index consultation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 11: CRP ‐ Sensitivity analysis: participant recovery within 7 days follow‐up: missing data in CRP = not recovered" data-id="CD010130-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 11: CRP ‐ Sensitivity analysis: participant recovery within 7 days follow‐up: missing data in CRP = not recovered </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 12: CRP ‐ Sensitivity analysis: participant recovery within 28 days follow‐up: missing data in CRP = not recovered (cluster‐randomised trials with modified sample size)" data-id="CD010130-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 12: CRP ‐ Sensitivity analysis: participant recovery within 28 days follow‐up: missing data in CRP = not recovered (cluster‐randomised trials with modified sample size) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 13: CRP ‐ Sensitivity analysis: recovery within 7 days follow‐up when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L)" data-id="CD010130-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 13: CRP ‐ Sensitivity analysis: recovery within 7 days follow‐up when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 14: CRP ‐ Sensitivity analysis: recovery within 28 days follow‐up when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L)" data-id="CD010130-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 14: CRP ‐ Sensitivity analysis: recovery within 28 days follow‐up when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 15: CRP ‐ Sensitivity analysis: antibiotics prescribed, assessed ONLY at day 28" data-id="CD010130-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 15: CRP ‐ Sensitivity analysis: antibiotics prescribed, assessed ONLY at day 28 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 16: CRP ‐ Sensitivity analysis: antibiotics prescribed, assessed WITHIN 28 days " data-id="CD010130-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 16: CRP ‐ Sensitivity analysis: antibiotics prescribed, assessed WITHIN 28 days  </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 17: CRP ‐ Sensitivity analysis: recovery, assessed ONLY at day 7" data-id="CD010130-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 17: CRP ‐ Sensitivity analysis: recovery, assessed ONLY at day 7 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 18: CRP ‐ Sensitivity analysis: recovery, assessed WITHIN 7 days" data-id="CD010130-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 18: CRP ‐ Sensitivity analysis: recovery, assessed WITHIN 7 days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 19: CRP ‐ Sensitivity analysis: recovery, assessed ONLY at day 28" data-id="CD010130-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 19: CRP ‐ Sensitivity analysis: recovery, assessed ONLY at day 28 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 20: CRP ‐ Sensitivity analysis: recovery, assessed WITHIN 28 days" data-id="CD010130-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 20: CRP ‐ Sensitivity analysis: recovery, assessed WITHIN 28 days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: C‐reactive protein versus standard care, Outcome 21: CRP ‐ Sensitivity analysis: antibiotic prescribing when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L)" data-id="CD010130-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: C‐reactive protein versus standard care, Outcome 21: CRP ‐ Sensitivity analysis: antibiotic prescribing when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 1: Procalcitonin ‐ Antibiotic prescribed at index consultation" data-id="CD010130-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 1: Procalcitonin ‐ Antibiotic prescribed at index consultation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 2: Procalcitonin ‐ Antibiotic prescribed within 28 days follow‐up" data-id="CD010130-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 2: Procalcitonin ‐ Antibiotic prescribed within 28 days follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 3: Procalcitonin ‐ Number of participants substantially improved within 7 days follow‐up" data-id="CD010130-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 3: Procalcitonin ‐ Number of participants substantially improved within 7 days follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 4: Procalcitonin ‐ Mortality" data-id="CD010130-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 4: Procalcitonin ‐ Mortality</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 5: Procalcitonin ‐ Number of reconsultations within 28 days follow‐up" data-id="CD010130-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 5: Procalcitonin ‐ Number of reconsultations within 28 days follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 6: Procalcitonin ‐ Hospital admissions" data-id="CD010130-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 6: Procalcitonin ‐ Hospital admissions </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010130-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/urn:x-wiley:14651858:media:CD010130:CD010130-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Procalcitonin versus standard care, Outcome 7: Procalcitonin ‐ Patient satisfaction" data-id="CD010130-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_t/tCD010130-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Procalcitonin versus standard care, Outcome 7: Procalcitonin ‐ Patient satisfaction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/media/CDSR/CD010130/image_n/nCD010130-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010130-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Point‐of‐care biomarkers (C‐reactive protein) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Point‐of‐care biomarker for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> people with acute respiratory infections </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> point‐of‐care biomarker (C‐reactive protein) test </p> <p><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Standard care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>at index consultation</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>516 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>397 per 1000</b> </p> <p>(356 to 444)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b> </p> <p>(0.69 to 0.86)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10218 </p> <p>(12 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> <p> </p> <p> </p> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>within 28 days follow‐up</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>664 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>538 per 1000 </b> </p> <p>(505 to 571)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.81</b> </p> <p>(0.76 to 0.86)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5091 </p> <p>(7 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b> </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 7 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>567 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>584 per 1000</b> </p> <p>(545 to 636)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b> </p> <p>(0.96 to 1.12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3104</p> <p>(4 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Defined as number of participants at least substantially improved at 7 days follow‐up </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality </b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000 </b> </p> <p>(0 to 2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b> (0.10 to 2.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7737</p> <p>(9 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies reported 5 events. 6 studies had no events. 3 studies did not report on death. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants in need of a hospital admission</b>  </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>14 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> </p> <p>(10 to 22)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> </p> <p>(0.72 to 1.53)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7514 </p> <p>(10 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 studies reported 105 events. 4 studies had no events. 2 studies did not report on hospital admission. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>897 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>915 per 1000</b> </p> <p>(724 to 1000)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.02</b> </p> <p>(0.79 to 1.32)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2324 </p> <p>(5 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Defined as number of participants at least substantially improved at 28 days of follow‐up </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The <b>assumed risk</b> was calculated as the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty</b> : we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty</b> : our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty</b>: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded one level due to substantial heterogeneity.<br/><sup>b</sup>We downgraded one level due to risk of bias (lack of blinding).<br/><sup>c</sup>We downgraded two levels due to substantial imprecision.<br/><sup>d</sup>We downgraded one level due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Point‐of‐care biomarkers (C‐reactive protein) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010130-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Point‐of‐care biomarkers (procalcitonin) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Point‐of‐care biomarker for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> people with acute respiratory infections </p> <p><b>Settings:</b> primary care </p> <p><b>Intervention:</b> point‐of‐care biomarker (procalcitonin) test </p> <p><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Standard care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>at index consultation</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>566 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>181 per 1000</b> </p> <p>(130 to 249)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.32</b> </p> <p>(0.23 to 0.44)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 </p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants given an antibiotic prescription </b> </p> <p>within 28 days follow‐up</p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b> </p> <p>(31 to 174)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> </p> <p>(0.44 to 2.48)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 7 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>395 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>486 per 1000</b> </p> <p>(367 to 639)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.23</b> </p> <p>(0.93 to 1.62)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality </b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable due to few participants and events. No events of death occurred in either intervention or control group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants in need of a hospital admission</b>  </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> <p>(9 to 264 more)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.40</b> </p> <p>(0.26 to 7.51)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical recovery</b> </p> <p>within 28 days follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable, as this outcome was not assessed in the included study</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> was calculated as the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty</b> : we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty</b> : our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty</b>: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded one level for study limitations (cluster‐randomised trial), one level for indirectness (study only included adults), and two levels for substantial imprecision (small sample size compared to the optimal information size). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Point‐of‐care biomarkers (procalcitonin) for infection compared with standard of care for guiding antibiotic therapy in acute respiratory infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of biomarkers of infection used in acute respiratory infection trials in primary care settings</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Biomarker</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Status</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Handling</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Biochemistry</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>POC test available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Droplet blood from finger prick. Results in approximately 3 minutes. Uninfected adult controls have levels &lt; 10 mg/L. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inflammatory cytokines trigger C‐reactive protein release by the liver. Levels of C‐reactive protein increase within 6 to 18 hours, peaking at 48 to 72 hours. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Leukocyte count</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>POC test available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Droplet blood from finger prick. Results in approximately 3 minutes. Uninfected adult controls have leukocyte levels &lt; 9 x 10⁹/L and neutrocyte levels &lt; 7 x 10⁹/L. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cells of the immune system activated by inflammatory cytokines and foreign antigens.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Procalcitonin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>POC test available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uninfected adult controls have levels &lt; 0.05 ng/mL.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inflammatory cytokines and bacterial endotoxins trigger release of PCT from parenchymal tissues. Levels of PCT increase within 2 to 6 hours, peaking at 24 to 48 hours. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>PCT: procalcitonin<br/>POC: point‐of‐care </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of biomarkers of infection used in acute respiratory infection trials in primary care settings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">C‐reactive protein ‐ duration of symptoms</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Mean (SD)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Median (IQR)</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 (14 to 28)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 (14 to 28)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.5 (9.2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.8 (9.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.5 (9.5 to 28)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 (13.5 to &gt; 28)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinosinusitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.3 (9.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.6 (9.9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (10 to 28)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (7 to &gt; 28)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ARTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (4 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (4 to7)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (3 to 9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 9)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>URTI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (3 to 8)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ARI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (3 to 9)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Abbreviations: ARI: acute respiratory tract infection (LRTI + URTI); IQR: interquartile range; LRTI: lower respiratory tract infection; SD: standard deviation; URTI: upper respiratory tract infection </p> <p><sup>a</sup>Reported as time to full recovery.<br/><sup>b</sup>Reported as time to resolution of symptoms.<br/><sup>c</sup>Reported as resolution of moderately bad or worse symptoms. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">C‐reactive protein ‐ duration of symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Procalcitonin ‐ duration of symptoms</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Mean (SD)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Median (IQR)</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>Abbreviations: IQR: interquartile range; SD: standard deviation</p> <p><sup>a</sup>Based on total symptoms score reported by participants within 28 days. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Procalcitonin ‐ duration of symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">C‐reactive protein ‐ baseline characteristics of included participantsa </span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Parameter</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Studies</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>C‐reactive protein group</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control group</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age, mean (SD)<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.1 (13.0)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.4 (13.1)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gender (female) % (n/N)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61.0 (4597/7542)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.6 (4258/7030)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Current smokers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.5 (1283/3020)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.9 (1173/2675)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comorbidity<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a>; <a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.3 (1014/3139)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.7 (862/2806)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Primary diagnosis</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclassified upper ARI<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.5 (499/2325)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.1 (446/2118)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.3 (13/394)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5 (17/374)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Common cold</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9 (15/108)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.8 (22/131)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinosinusitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.3 (143/523)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.2 (137/502)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total upper ARI<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a>; <a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.7 (670/2956)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.6 (622/2752)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.7 (16/209)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.4 (30/209)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI/acute cough</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74.3 (2364/3183)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.5 (2173/2956)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bronchitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.9 (41/108)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.1 (42/131)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbations of COPD or asthma</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.8 (341/433)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.7 (335/437)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total lower ARI<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.8 (2446/3183)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70.5 (2271/2956)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3 (9/108)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.2 (12/131)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other respiratory diseases</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a>; <a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3 (67/502)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.1 (66/505)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations: ARI: acute respiratory infection; COPD: chronic obstructive pulmonary disease; LRTI: lower respiratory tract infection; SD: standard deviation </p> <p><sup>a</sup>Crude numbers provided from all studies regardless of design.<br/><sup>b</sup><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> reported the median age: 50 (range 18 to 83) in the C‐reactive protein arm versus 44 (18 to 82) in the control arm. <a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> reported median age 16 (8 to 39) in the C‐reactive protein arm versus 15 (8 to 41) in the control arm. <a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> reported the median age 3 (0 to 11) in the C‐reactive protein arm versus 2 (0 to 11) in the control arm.<br/><sup>c</sup>COPD; asthma; heart disease; diabetes mellitus.<br/><sup>d</sup>Acute respiratory infection.<br/><sup>e</sup>Any upper acute respiratory infections.<br/><sup>f</sup>Any lower acute respiratory infections. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">C‐reactive protein ‐ baseline characteristics of included participantsa </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0007"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Procalcitonin ‐ baseline characteristics of included participants</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Parameter</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Procalcitonin group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control group</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age, mean (SD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 (18.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 (18.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gender (female) % (n/N)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 (126/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 (65/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Current smokers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 (44/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (31/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comorbidity<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.5 (75/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.6 (52/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Primary diagnosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclassified upper ARI<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otitis media</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Common cold</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinosinusitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total upper ARI<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LRTI/acute cough</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (195/195)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 (122/122)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbations of COPD or asthma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total lower ARI<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Influenza</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other respiratory diseases</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations: ARI: acute respiratory infection; COPD: chronic obstructive pulmonary disease; LRTI: lower respiratory tract infection; SD: standard deviation </p> <p><sup>a</sup>COPD; asthma; heart disease; diabetes.<br/><sup>b</sup>Acute respiratory infections.<br/><sup>c</sup>Any upper respiratory infection.<br/><sup>d</sup>Any lower acute respiratory infection. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Procalcitonin ‐ baseline characteristics of included participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0008"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">C‐reactive protein ‐ inclusion criteria and C‐reactive protein algorithms of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomisation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Inclusion criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Algorithm used*</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0012" title="MelbyeH , AaraasI , FletenN , KolstrupN , Mikalsen J-I. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C-reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen1995;115(13):1610-5. ">Melbye 1995</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with subjective complaint of i) pneumonia, bronchitis, or asthma (no further description); or ii) 1 of the following symptoms: cough, shortness of breath, chest pain on deep inspiration or when coughing </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of illness <b>&lt; 24 hours</b> and C‐reactive protein levels lower than 50 mg/L: no change in clinical decision. C‐reactive protein levels &gt; 50 mg/L: immediate antibiotic prescribing was recommended </p> <p>Duration of illness <b>1 to 6 days</b> and C‐reactive protein levels &lt; 11 mg/L: no antibiotics recommended. Participants with C‐reactive protein levels between 11 and 49 mg/L: no change in clinical decision. C‐reactive protein levels &gt; 50 mg/L: immediate antibiotic prescribing was recommended </p> <p>Duration of illness <b>&gt; 7 days</b> and C‐reactive protein levels &lt; 11 mg/L: no antibiotics recommended. Participants with C‐reactive protein levels between 11 and 24 mg/L: no change in clinical decision. C‐reactive protein levels &gt; 25 mg/L: immediate antibiotic prescribing was recommended </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0007" title="DiederichsenHZ , SkamlingM , DiederichsenA , GrinstedP , AntonsenS , PetersenPH , et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care2000;18:39-43. ">Diederichsen 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients with a respiratory infection (no further description)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Strict cut‐off values were not given, but information was provided that a normal C‐reactive protein level was <b>&lt; 10 mg/L</b> and that C‐reactive protein levels <b>&lt; 50 mg/L</b> were seldom the result of bacterial infection. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0005" title="CalsJW , ButlerCC , HopstakenRM , HoodK , DinantGJ . Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ2009;338:b1374. [DOI: 10.1136/bmj.b1374]">Cals 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with suspected LRTI (cough &lt; 4 weeks AND</p> <p>1 focal sign/symptom (shortness of breath, wheezing, chest pain, auscultation abnormalities) AND </p> <p>1 systemic sign/symptom (fever &gt; 38 °C, perspiring, headache, myalgia, feeling generally unwell) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 20 mg/L</b>: pneumonia extremely unlikely and antibiotic prescribing discouraged </p> <p>C‐reactive protein levels between <b>20 and 50 mg/L</b>: pneumonia very unlikely </p> <p>C‐reactive protein levels between <b>50 and 100 mg/L</b>: clear infection. Acute bronchitis most likely, possible pneumonia </p> <p>C‐reactive protein <b>&gt; 100 mg/L</b>: severe infection. Pneumonia more likely. Immediate antibiotic prescribing was recommended. </p> <p>C‐reactive protein levels between <b>20 and 99 mg/L</b>: consider delayed prescribing </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0006" title="CalsJW , SchotMJ , deJongSA , DinantGJ , HopstakenRM . Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Annals of Family Medicine2010;8(2):124-33. [DOI: 10.1370/afm.1090]">Cals 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with:</p> <p>i) LRTI (cough &lt; 4 weeks) AND</p> <p>1 focal sign/symptom (shortness of breath, wheezing, chest pain, auscultation abnormalities) AND </p> <p>1 systemic sign/symptom (fever &gt; 38 °C, perspiring, headache, myalgia, feeling generally unwell) </p> <p>ii) Rhinosinusitis &lt; 4 weeks AND</p> <p>1 symptom (history of rhinorrhoea, blocked nose)</p> <p>1 symptom or sign (purulent rhinorrhoea, unilateral facial pain, headache, teeth pain, pain when chewing, maxillary/frontal pain when bending over, worsening of symptoms after initial improvement) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 20 mg/L</b>: bacterial infection was considered highly unlikely and antibiotic prescribing was discouraged </p> <p>C‐reactive protein levels <b>&gt; 100 mg/L</b>: bacterial infection was considered likely and immediate antibiotic prescribing was recommended </p> <p>C‐reactive protein levels between <b>20 and 99 mg/L</b>: consider delayed prescribing </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0010" title="LittleP , StuartB , FrancisN , Tonkin-CrineS , DouglasE , AnthierensS , et al. The effect of web-based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi-national cluster randomised factorial controlled trial. Lancet2013;382(9899):1175-82. ">Little 2013a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with:</p> <p>i) LRTI/acute cough (up to 28 days' duration) as the main symptom, or alternatively where cough was not the most prominent symptom (e.g. fever, malaise), but where the clinician considered acute LRTI to be the main diagnosis. Pneumonia was not an exclusion criterion. </p> <p>ii) URTI: as with LRTI, but judged by the physician to be another acute respiratory infection (sore throat, otitis media, sinusitis, influenza and/or coryzal illness) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b>: self‐limiting ARI, withhold antibiotics </p> <p>C‐reactive protein <b>21 to 50 mg/L</b>: majority of participants have self‐limiting ARI, withhold antibiotics in most cases </p> <p>C‐reactive protein <b>51 to 99 mg/L</b>: withhold antibiotics in the majority of cases and consider delayed antibiotics in the minority of cases </p> <p>C‐reactive protein <b>≥ 100 mg/L</b>: severe infection, prescribe antibiotics </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0002" title="AndreevaE , MelbyeH . Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomised clinical trial with CRP testing in the intervention group. BMC Family Practice2014;15:80. ">Andreeva 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with LRTI/acute cough (including acute bronchitis, pneumonia, and infectious exacerbations of COPD or asthma) for less than 28 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>&lt; 20 mg/L</b>: antibiotics usually not needed </p> <p>C‐reactive protein <b>&gt; 50 mg/L</b>: antibiotic prescribing could be indicated taking into account the duration of illness </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0008" title="DoNT , TaNT , TranNT , ThanHM , VuBT , HoangLB , et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Global Health2016;4:e633–41. ">Do 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients aged 1 to 65 years of age presenting with non‐severe acute respiratory tract infection with at least 1 focal and 1 systemic sign or symptom by the treating physician.  </p> <p>Focal signs; cough, rhinitis, pharyngitis, shortness of breath, wheezing, chest pain, and auscultation abnormalities  </p> <p>Systemic signs and symptoms; fever, perspiration, headache, myalgia, and feeling generally unwell </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b> for participants aged 6 to 65 years: prescription of antibiotics not recommended  </p> <p>C‐reactive protein <b>≥ 100 mg/L</b> for participants aged 6 to 65 years: should generally receive antibiotics, and hospital referral should be considered </p> <p> </p> <p>C‐reactive protein <b>≤ 10 mg/L</b> for children aged 1 to 5 years: prescription of antibiotics not recommended </p> <p>C‐reactive protein <b>≥ 50 mg/L</b> for children aged 1 to 5 years: should generally receive antibiotics, and hospital referral should be considered.  </p> <p> </p> <p>Between these thresholds no specific recommendation was given, and clinicians were advised to use their clinical discretion. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0013" title="SchotMJ , Van den BruelA , BroekhuizenBD , CalsJW , NoteboomEA , BalemansW , et al. Point-of-care C-reactive protein to assist in primary care management of children with suspected non-serious lower respiratory tract infection: a randomised controlled trial. BJGP Open2018;2(3):1-10. [DOI: 10.3399/bjgpopen18X101600]">Schot 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children between 3 months and 12 years of age with suspicion of lower respiratory tract infection; acute cough &lt; 21 days; reported fever &gt; 38 °C &lt; 5 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 10 mg/L</b> make pneumonia less likely, but should not be used to exclude pneumonia when the GP finds the child ill, or when duration of symptoms is &lt; 6 hours </p> <p>C‐reactive protein between <b>10 mg/L and 100 mg/L</b>, the likelihood of pneumonia increases with increasing CRP levels </p> <p>C‐reactive protein levels<b>&gt; 100 mg/L</b> make pneumonia much more likely; however, such levels can also be caused by viral infections </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0001" title="AlthausT , GreerRC , SweMM , CohenJ , TunNN , HeatonJ , et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Global Health2019;7:e119-31. ">Althaus 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients aged 1 year or older with:</p> <p>a documented fever (defined as a tympanic temperature of &gt; 37.5 °C according to WHO standards) OR  </p> <p>a chief complaint of fever (&lt; 14 days), regardless of previous antibiotic intake and comorbidity other than malignancies </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention group A: the result of CRP measurement was communicated to the healthcare provider as low CRP or high CRP using cut‐off thresholds of <b>20 mg/L</b> </p> <p> </p> <p>Intervention group B: the result of CRP measurement was communicated to the healthcare provider as low CRP or high CRP using cut‐off thresholds of<b>40 mg/L</b> </p> <p> </p> <p>If CRP measurement was <b>low</b>, antibiotics should be refrained from if no danger signs were present.  </p> <p>If CRP measurement was <b>high</b>, antibiotics should be considered on the basis of clinical judgement. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0004" title="ButlerCC , GillespieD , WhiteP , BatesJ , LoweR , Thomas-JonesE , et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. PACE Study. New England Journal of Medicine2019;381:111-20. ">Butler 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients aged 40 years or older and diagnosis of COPD in their primary care clinical record; presenting with an acute exacerbation of COPD with at least 1 of AECOPD criteria (increased dyspnoea, increased sputum volume, increased sputum purulence), between 24 hours and 21 days duration </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b>: antibiotics are unlikely to be beneficial and should usually not be prescribed </p> <p>C‐reactive protein <b>20 to 40 mg/L</b>: antibiotics may be beneficial, mainly if purulent sputum is present </p> <p>C‐reactive protein <b>≥ 40 mg/L</b>: antibiotics are likely to be beneficial </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0011" title="LittleP , StuartB , FrancisN , DouglasE , Tonkin-CrineS , AnthierensS , et al, GRACE consortium. Antibiotic prescribing for acute respiratory tract infections 12 months after communication and CRP training: a randomized trial. Annals of Family Medicine2019;17(2):125-32. [DOI: 10.1370/afm.2356]">Little 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with:</p> <p>i) LRTI/acute cough (up to 28 days duration) as the main symptom, or alternatively where cough was not the most prominent symptom (e.g. fever, malaise), but where the clinician considered acute LRTI to be the main diagnosis. Pneumonia was not an exclusion criterion. </p> <p>ii) URTI: as with LRTI, but judged by the physician to be another acute respiratory infection (sore throat, otitis media, sinusitis, influenza and/or coryzal illness) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein <b>≤ 20 mg/L</b>: self‐limiting ARI, withhold antibiotics </p> <p>C‐reactive protein <b>21 to 50 mg/L</b>: the majority of patients have self‐limiting ARI, withhold antibiotics in most cases </p> <p>C‐reactive protein <b>51 to 99 mg/L</b>: withhold antibiotics in the majority of cases and consider delayed antibiotics in the minority of cases </p> <p>C‐reactive protein <b>≥ 100 mg/L</b>: severe infection, prescribe antibiotics </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0003" title="BoereTM , vanBuulLW , HopstakenRM , vanTulderMW , TwiskJW , VerheijTJ , et al. C-reactive protein point-of-care testing reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents: results of a cluster randomized, controlled trial. BMJ2021;374:1-8. ">Boere 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All somatic, psychogeriatric, and short‐stay (geriatric rehabilitation and short‐term residential care) nursing home residents with a suspected LRTI, according to their physician’s assessment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C‐reactive protein levels <b>&lt; 20 mg/L</b>: self‐limiting LRTI. Assessment of signs, symptoms, risk factors, and CRP is important. Withhold antibiotics in most cases </p> <p>C‐reactive protein levels <b>20 to 60 mg/L</b>: assessment of signs, symptoms, risk factors, and CRP is important. Withhold antibiotics in most cases </p> <p>C‐reactive protein levels <b>&gt; 60 mg/L</b>: severe infection, prescribe antibiotics </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>Abbreviations: AECOPD: acute exacerbations of chronic obstructive pulmonary disease; ARI: acute respiratory infection; COPD: chronic obstructive pulmonary disease; CRP: C‐reactive protein; GP: general practitioner; LRTI: lower respiratory tract infection; URTI: upper respiratory tract infection; WHO: World Health Organization </p> <p>*All studies stated that physicians could deviate from the algorithm at any time.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">C‐reactive protein ‐ inclusion criteria and C‐reactive protein algorithms of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0009"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Procalcitonin ‐ inclusion criteria and procalcitonin algorithms of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Randomisation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Inclusion criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Algorithm used</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010130-bbs2-0009" title="LhopitallierL , KronenbergA , MeuwlyJ , LocatelliI , MuellerY , SennN , et al. Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial. BMJ2021;374:n2132. [DOI: 10.1136/bmj.n2132]">Lhopitallier 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults (&gt; 18 years) with acute cough &lt; 21 days and at least 1 of the following signs/symptoms: history of fever for more than 4 days; dyspnoea; tachypnoea (&gt; 22 cycles per minute); abnormal focal findings upon lung auscultation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Procalcitonin ≥ 0.25 μg/L: antibiotics prescribing recommended</p> <p> </p> <p>Antibiotic choice, dose, and duration were left to the discretion of the primary care physician. The physician could also order further diagnostic tests. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Procalcitonin ‐ inclusion criteria and procalcitonin algorithms of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0010"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">C‐reactive protein ‐ number needed to test to save 1 antibiotic prescribing</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>NNT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>95% CI</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual RCT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cluster‐RCT*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 to 20</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; NNT: number needed to test; RCT: randomised controlled trial </p> <p>*Cluster‐randomised trials with modified sample size.<br/>  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">C‐reactive protein ‐ number needed to test to save 1 antibiotic prescribing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0011"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">C‐reactive protein ‐ summary of secondary outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pooled results<sup>a</sup> </b> </p> <p><b>RR (95% CI); I²</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Individually randomised</b> </p> <p><b>RR (95% CI); I²</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cluster‐randomised</b> </p> <p><b>RR (95% CI); I²</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysis</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reconsultations day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06 (0.91 to 1.24); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.31 (0.90 to 1.89); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.01 (0.85 to 1.20); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.05 (0.72 to 1.53); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.69 to 1.51); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48 (0.36 to 6.17); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (0.50 to 1.29); 40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.15 (0.22 to 6.17); 62%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.55 to 1.51); 40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recovery day 28<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.79 to 1.32); 0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.8</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; RR: risk ratio</p> <p><sup>a</sup>When I² &gt; 40%, separate analyses of individually and cluster‐randomised trials are presented.<br/><sup>b</sup>Defined as at least substantial improvement. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">C‐reactive protein ‐ summary of secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010130-tbl-0012"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Procalcitonin ‐ summary of secondary outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Analysis</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reconsultations day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (0.69 to 1.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.40 (0.26 to 7.51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient satisfaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (0.93 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.7</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; RR: risk ratio</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Procalcitonin ‐ summary of secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/full#CD010130-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010130-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">C‐reactive protein versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 CRP ‐ Antibiotics prescribed at index consultation. All trials (cluster‐randomised with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.69, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5899</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.70, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 CRP ‐ Antibiotics prescribed within 28 days follow‐up (cluster‐randomised trials with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5091</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.76, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4880</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.77, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.51, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 CRP ‐ Number of participants substantially improved within 7 days follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.96, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.96, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 CRP ‐ Mortality (cluster‐randomised trials with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.10, 2.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.06, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.04, 7.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 CRP ‐ Number of reconsultations within 28 days follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.91, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.90, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2057</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.85, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 CRP ‐ Hospital admissions (cluster‐randomised with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.72, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.69, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Cluster‐randomised trials (modified sample sizes)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.36, 6.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 CRP ‐ Patient satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.50, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.22, 6.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.55, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 CRP ‐ Number of participants substantially improved within 28 days follow‐up (cluster‐randomised trials with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.79, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 CRP ‐ Subgroup analysis: antibiotics prescribed at index consultation: upper respiratory tract infections and lower respiratory tract infections (cluster‐randomised trials with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2024</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.63, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Upper respiratory tract infections</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.58, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Lower respiratory tract infections</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.62, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 CRP ‐ Subgroup analysis: children and adults. Antibiotic prescribing at index consultation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.70, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Children (cluster‐randomised trials with modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.67, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.68, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 CRP ‐ Sensitivity analysis: participant recovery within 7 days follow‐up: missing data in CRP = not recovered <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [1.03, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 CRP ‐ Sensitivity analysis: participant recovery within 28 days follow‐up: missing data in CRP = not recovered (cluster‐randomised trials with modified sample size) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.01, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 CRP ‐ Sensitivity analysis: recovery within 7 days follow‐up when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1522</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.93, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 CRP ‐ Sensitivity analysis: recovery within 28 days follow‐up when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1938</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.87, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 CRP ‐ Sensitivity analysis: antibiotics prescribed, assessed ONLY at day 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.72, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.70, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 CRP ‐ Sensitivity analysis: antibiotics prescribed, assessed WITHIN 28 days  <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5091</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.72, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4880</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.73, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.51, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 CRP ‐ Sensitivity analysis: recovery, assessed ONLY at day 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.87, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.87, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 CRP ‐ Sensitivity analysis: recovery, assessed WITHIN 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.91, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.91, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 CRP ‐ Sensitivity analysis: recovery, assessed ONLY at day 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.69, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 CRP ‐ Sensitivity analysis: recovery, assessed WITHIN 28 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.70, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 CRP ‐ Sensitivity analysis: antibiotic prescribing when algorithms provide clear cut‐offs to rule out (&lt; 20 mg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.65, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.1 Individually randomised trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.66, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.2 Cluster‐randomised trials (modified sample size)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.56, 0.91]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">C‐reactive protein versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010130-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Procalcitonin versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Procalcitonin ‐ Antibiotic prescribed at index consultation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.23, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Procalcitonin ‐ Antibiotic prescribed within 28 days follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.44, 2.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Procalcitonin ‐ Number of participants substantially improved within 7 days follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.93, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Procalcitonin ‐ Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Procalcitonin ‐ Number of reconsultations within 28 days follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.69, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Procalcitonin ‐ Hospital admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.26, 7.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Procalcitonin ‐ Patient satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.93, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Procalcitonin versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010130.pub3/references#CD010130-tbl-0014">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010130.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010130-note-0015">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010130-note-0021">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010130-note-0026">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010130-note-0019">Français</a> </li> <li class="section-language"> <a class="" href="hu#CD010130-note-0020">Magyar</a> </li> <li class="section-language"> <a class="" href="ja#CD010130-note-0025">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD010130-note-0017">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010130-note-0018">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010130-note-0027">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD010130-note-0016">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD010130-note-0024">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010130-note-0022">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010130-note-0023">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010130\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010130\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010130\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010130\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010130\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010130.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010130.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010130.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010130.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010130.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714340721"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010130.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714340725"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010130.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6c4c5cfcf3cd',t:'MTc0MDcxNDM0MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 